Connecticut Guidelines for a Clinical Diagnosis of Autism Spectrum Disorder by University of Connecticut School of Medicine and Dentistry
University of Connecticut
OpenCommons@UConn
Articles - Patient Care Patient Care
2013
Connecticut Guidelines for a Clinical Diagnosis of
Autism Spectrum Disorder
University of Connecticut School of Medicine and Dentistry
Follow this and additional works at: https://opencommons.uconn.edu/pcare_articles
Part of the Medicine and Health Sciences Commons
Recommended Citation
University of Connecticut School of Medicine and Dentistry, "Connecticut Guidelines for a Clinical Diagnosis of Autism Spectrum
Disorder" (2013). Articles - Patient Care. 45.
https://opencommons.uconn.edu/pcare_articles/45
CONNECTICUT GUIDELINES For a Clinical Diagnosis of 
AUTISM SPECTRUM 
DISORDER
To download a copy of The Connecticut Guidelines for a Clinical Diagnosis of Autism 
Spectrum Disorder, please visit  http://www.uconnucedd.org/actearlyct. 
If you require assistance, please contact The University of Connecticut Center  
for Excellence in Developmental Disabilities at 860-679-1500  
or Toll Free 1-866-623-1315 or TTY 860-679-1502.
C
o
n
n
e
c
t
i
c
u
t
 G
u
i
d
e
l
i
n
e
s
 F
o
r
 a
 C
l
i
n
i
c
a
l
 D
i
a
g
n
o
s
i
s
 o
f
 A
u
t
i
s
m
 S
p
e
c
t
r
u
m
 D
i
s
o
r
d
e
r
CONNECTICUT GUIDELINES FOR 
A CLINICAL DIAGNOSIS OF 
AUTISM SPECTRUM DISORDER
COPYRIGHT INFORMATION 
This publication was developed as a partnership with multiple stakeholders throughout Connecticut. All rights under federal copyright laws 
are held by the University of Connecticut Center for Excellence in Developmental Disabilities except for the previously published materials 
included in this document and published in 2013. 
All parts of this publication, except for previously published materials credited to the authors and/or publishers may be reproduced in any 
form of printed or visual medium. Any reproduction of this publication may not be sold for profit or reproduction costs without the exclusive 
permission of the University of Connecticut Center for Excellence in Developmental Disabilities. Any reproduction of this publication, in 
whole or in part, shall acknowledge, in writing, the University of Connecticut Center for Excellence in Developmental Disabilities.
This publication is available at no charge at http://www.uconnucedd.org/actearlyct/.
Previously published surveillance and screening algorithms and diagnostic criteria included in this document are reprinted with permission 
from the author and/or publishers and are for personal use only. They may not be reproduced without the express written consent of the author 
and/or publisher.
Connecticut Guidelines for a Clinical Diagnosis of Autism Spectrum Disorder — 1 — 
Table of Contents
Acknowledgments ...........................................................................................................................................4
Preface ..................................................................................................................................................................5
Chapter 1: Autism Spectrum Disorder ....................................................................................................9
History of Diagnostic Criteria ........................................................................................................................10
Description of Current Diagnostic Criteria .....................................................................................................10
Pervasive Developmental Disorders of DSM-IV and ICD-10 ........................................................................11
Chapter 2: The Diagnostic Evaluation ...................................................................................................15
Child and Family/Caregiver History ..............................................................................................................16
Assessment of Core Features ..........................................................................................................................19
Comprehensive Medical Examination ............................................................................................................24
Differential Diagnoses and Co-Occurring Conditions ....................................................................................27
Additional Considerations for the Diagnostic Evaluation ..............................................................................35
Chapter 3: Evaluation Results ..................................................................................................................45
Oral Feedback to the Family ...........................................................................................................................46
The Written Evaluation Report .......................................................................................................................50
Sharing Diagnostic Information .....................................................................................................................51
Chapter 4: The Use of the Evaluation for Early Intervention and Special Education .......53
Eligibility Determination for Children Ages Birth to Three ...........................................................................54
Eligibility Determination for Children Ages Three Through Twenty-One.....................................................55
Developmental Delay .....................................................................................................................................56
Summary .........................................................................................................................................................56
References .........................................................................................................................................................57
Appendices
Appendix A AAP Surveillance and Screening Algorithms & CDC Developmental  
 Screening Fact Sheet ..............................................................................................................64
Appendix B Diagnostic and Statistical Manual of Mental Disorders, 5th edition
 & Crosswalk of Diagnostic Criteria for DSM-IV-TR Autistic Disorder  
 and DSM-5 Autism Spectrum Disorder .................................................................................70
Appendix C Diagnostic and Statistical Manual of Mental Disorders, IV-TR 
	 &	Definition	of	Childhood	Autism	from	International	Classification	 
 of Diseases and Related Disorders, 10th edition ....................................................................74
Appendix D Additional Standardized Measures .........................................................................................79
Appendix E  NICE Guidelines for Diagnosis of Older Children ...............................................................86
Appendix F Child Development Infoline & Connecticut Medical Home Initiative ..................................88
— 2 — Connecticut Guidelines for a Clinical Diagnosis of Autism Spectrum Disorder
Connecticut Act Early Leadership 
Mary Beth Bruder, PhD, Chair, Act Early 
Connecticut
University of Connecticut Center 
for Excellence in Developmental 
Disabilities Education, Research and 
Service
Carol Weitzman, MD, Chair, Connecticut 
Guidelines Work Group
Yale University School of Medicine
Tierney Giannotti, MPA, Act Early 
Ambassador
University of Connecticut Center 
for Excellence in Developmental 
Disabilities Education, Research and 
Service
Work Group Members
Muhammad Waqar Azeem, MD, 
DFAACAP, DFAPA
Albert J. Solnit Children’s Center, 
Department of Children and Families
Ruth Eren, EdD 
Center for Excellence in Autism 
Spectrum Disorders, Southern 
Connecticut State University
Linda Goodman, MS, MPA
Birth to Three System, Department of 
Developmental Services 
Laura Kern, JD
Parent
Linda Rammler, MEd, PhD
University of Connecticut Center 
for Excellence in Developmental 
Disabilities Education, Research and 
Service
Brian Reichow, PhD, BCBA-D
Center for Excellence in Autism 
Spectrum Disorders, Southern 
Connecticut State University; Yale 
Child Study Center; University of 
Connecticut Center of Excellence in 
Developmental Disabilities Research, 
Education, and Service
Maria Synodi, MA
Bureau of Special Education, State 
Department of Education
Connecticut Guidelines for a Clinical Diagnosis of Autism Spectrum Disorder — 3 — 
Advisory Group Members
Cathy Adamczyk
Connecticut Council on Developmental 
Disabilities
Marianne Barton, PhD
University of Connecticut, Department of 
Psychology
Sandra Carbonari, MD
Connecticut Chapter of the American 
Academy of Pediatrics; St. Mary’s 
Hospital
Patricia Cronin
Department of Social Services
Kareena DuPlessis
Child Development Infoline
Christine H. Durant, MS, MA, CAGS
Retired Teacher
Kathleen Dyer, PhD, CCC-SLP, BCBA-D
Capitol Region Education Council, River 
Street Autism Program at Coltsville
Ann Gionet
Children and Youth with Special Health 
Care Needs Program, Department of 
Public Health
 Kathy Koenig, MSN, APRN
Yale Child Study Center
Ann Milanese, MD
Connecticut Children’s Medical Center
John Molteni, PhD, BCBA-D
University of St. Joseph Connecticut and 
Hospital for Special Care
Christine Peck PsyD, BCBA-D
Cooperative Educational Services
John Pelegano, MD
Hospital for Special Care
Jacob F. Pratt
Autism Spectrum Differences Institute 
of New England
Lois Rosenwald 
Autism Services & Resources 
Connecticut
Cindy Sarnowski
The Children’s Home
Robyn Trowbridge
Parent
Bethanne Vergean
Community Renewal Team
Doriana Vicedomini 
Connecticut Autism Action Coalition
Fredericka Wolman, MD
Department of Children and Families
— 4 — Connecticut Guidelines for a Clinical Diagnosis of Autism Spectrum Disorder
Acknowledgments
The publication of the Connecticut Guidelines for a Clinical Diagnosis of Autism 
Spectrum Disorder is a result of collaborative efforts from multiple stakeholders throughout 
Connecticut that were initiated under the Connecticut Act Early Project. We gratefully 
acknowledge and thank:
•	 The Connecticut Department of Developmental Services, Connecticut Department of 
Public Health, Children and Youth with Special Health Care Needs Program MCHB 
State Implementation Grant for Improving Services for Children and Youth with Autism 
Spectrum Disorders (ASD), and the University of Connecticut Center for Excellence in 
Developmental Disabilities for funding the creation and publication of these guidelines.
•	 The Centers for Disease Control and Prevention Learn the Signs. Act Early campaign.
•	 The families in Connecticut with children with ASD and individuals in Connecticut with 
ASD. Their experiences, insights and expertise have shaped the document into one that will 
provide other families, individuals and professionals with clear guidelines leading to an 
earlier diagnosis. 
•	 The professionals who work with children with ASD and their families on a daily basis, 
especially diagnosticians. 
•	 Dr. John Mantovani for his assistance with the project’s kick-off and the work of the 
Missouri Autism Guidelines Initiative which served as a model for the work conducted in 
Connecticut (Missouri Department of Health, 2010). 
•	 The work group members and their respective agencies/organizations who gave generously 
and enthusiastically of their time, expertise, and experience to develop this document. 
•	 The advisory group members who provided critical input to the document, including Brian 
Farrell, Mark Greenstein, MD, and Rhea Paul, PhD, CCC-SLP for their participation on the 
advisory group through 2012.
Connecticut Guidelines for a Clinical Diagnosis of Autism Spectrum Disorder — 5 — 
Preface
Overall, the number of children who are diagnosed with autism spectrum disorders 
(ASD) has increased. The Centers for Disease Control (CDC; CDC, 2012a) now estimates 
that 1 in 88 children have ASD (1 in 54 boys and 1 in 252 girls). This represents a 23% 
increase from data collected two years previously (CDC, 2009). This increased prevalence 
suggests that there is a growing need for screening and further referral, when indicated, for a 
diagnostic evaluation for children suspected of having ASD. To receive appropriate diagnostic 
services, a child must be able to obtain a comprehensive evaluation conducted by competent 
and qualified personnel using a protocol of acceptable tools and procedures. This is especially 
critical since early diagnosis of ASD is needed to help children and their families to realize the 
positive outcomes that can be achieved by participating in appropriate intervention services 
at the earliest point (e.g., National Research Council, 2001; Volkmar, Reichow, & Doehring, 
2011). It is essential then that parents, providers and educators remain vigilant in ensuring that 
all children, regardless of gender, race, ethnicity or socioeconomic status are appropriately 
diagnosed as early as possible, and provided with the individualized services that can lead 
to optimal outcomes. This document contains guidelines to meet the need for a common 
understanding across Connecticut regarding the elements essential in making an accurate 
diagnosis of ASD.
The Connecticut Guidelines for a Clinical Diagnosis of Autism Spectrum Disorder 
(hereafter referred to as Guidelines) are a result of collaborative efforts that were initiated 
under the Connecticut Act Early Project. This project began in 2007 as a partnership among 
the National Center on Birth Defects and Developmental Disabilities at the Centers for Disease 
Control and Prevention (CDC), the Maternal and Child Health Bureau (MCHB) at the Health 
Resources and Services Administration (HRSA) and the Association of University Centers on 
Disabilities (AUCD). As part of the Act Early Campaign, regional summits of state teams were 
held during 2008-2010, with a Connecticut team participating in the New England Act Early 
Summit in Providence, Rhode Island in April 2010. The team consisted of representatives from 
the University of Connecticut Center for Excellence in Developmental Disabilities Education, 
Research and Service; the Connecticut Leadership Education in Neurodevelopmental and 
related Disabilities (both of the University of Connecticut Health Center);  the Yale Child 
Study Center and the Yale Developmental-Behavioral Pediatrics Program (both of the Yale 
School of Medicine); Connecticut Children’s Medical Center; Hospital for Special Care; the 
Connecticut State Departments of Children and Families, Developmental Services, Social 
Services; the Connecticut Office of Protection and Advocacy for Persons with Disabilities; the 
Connecticut chapter of the American Academy of Pediatrics; a local Head Start Agency; parent 
advocacy organizations. Parents of children and adults who have ASD were also on the team.
During the summit, the Connecticut Act Early Team developed plans to address the 
state need for improvement with the early identification, diagnosis and intervention of young 
children with ASD. To represent this mission, the team adopted the following 10 year vision 
for Connecticut:
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In order to assure valued life outcomes, all of Connecticut’s diverse families and other 
stakeholders will be aware of the early signs of ASD and have knowledge about, and access to, 
evidenced-based, individualized, and timely screening, diagnostic evaluation and interventions 
implemented by a competent work force and a funded, coordinated system of care.
In order to realize this vision, the team felt that a number of service components had 
to be defined and adopted throughout the state.  In particular, the team decided to focus on the 
development of Connecticut diagnostic guidelines for the identification of young children with ASD. 
To begin the process, the Act Early Team identified a number of principles to guide the 
development of the guidelines. These follow: 
1. Early identification of children with ASD through accurate screening and diagnosis 
is essential to access individualized and effective interventions that result in optimal 
outcomes. While it is out of the purview of this document, the American Academy 
of Pediatrics recommends general developmental screening at the 9-, 18- and 30- 
month well child visits. Screening of all children for ASD using a standardized 
screening instrument is recommended at the 18 month visit and again at the 24 
month visit, and whenever parents raise a concern about their child’s development 
(see Johnson & Myers, 2007). See Appendix A for the American Academy of 
Pediatrics surveillance and screening algorithms. 
2. Everyone in Connecticut, including diverse and underrepresented groups, should 
have easy and equitable access to diagnostic evaluations and intervention services. 
The Guidelines should not impede access to services for children and families, nor be 
interpreted as limiting a diagnostician’s approach to assessing and evaluating children. 
3. A family-centered approach is the foundation of all diagnostic services and 
interventions, and is represented throughout the Guidelines. 
4. A medical home approach provides comprehensive primary care that is accessible, 
continuous, comprehensive, family-centered, coordinated, compassionate, and 
culturally effective. A medical home facilitates partnership between a child’s family 
or caregiver, the child, and the primary health care provider (American Academy 
of Pediatrics, n.d.; http://www.medicalhomeinfo.org/), and the concept is supported 
through these Guidelines. 
5. Information on existing state policies and programs for children with ASD (e.g., 
Birth to Three, special education, insurance coverage) should be made available and 
accessible to all.  
6. While the focus of the Guidelines is on the early identification and diagnosis of 
young children with ASD, the principles included in the document apply to all 
children suspected of a disability or developmental delay. 
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7. Current research and scientific evidence should inform diagnostic evaluations to 
enable earlier and more accurate identification of children with ASD who live in 
Connecticut. 
To accomplish this a multidisciplinary 12 member work group consisting of parents, 
autism researchers, educators, and practitioners from developmental behavioral pediatrics, 
early intervention, public schools/special education, developmental psychology, child 
psychiatry and law was enlisted to write the guidelines. The work group met monthly to draft 
the guidelines, using a facilitator to discuss the content and format of the guidelines. These 
discussions were recorded and written into a working document by one member of the group 
who was responsible for developing the written draft of the guidelines. Between meetings, the 
workgroup reviewed, edited and resolved differences on the written drafts.
The work of the work group was supported by a larger advisory group of 24 experts 
from Connecticut including parents of children with ASD, self-advocates, psychologists, 
professionals who inform intervention planning processes, educators, early intervention 
providers, and representatives of multiple state agencies serving children and families. 
This larger group brought together diverse perspectives to ensure that the guidelines were 
relevant to the evidence on best practice in diagnostic evaluation, as well as the Connecticut 
service delivery system. The larger advisory group was involved in three meetings during the 
process in order to review and approve decisions about key components of the guidelines. 
Most importantly, the group provided feedback on the social validity of the guidelines to 
diagnosticians, families, higher education faculty, public school administrators and personnel, 
advocates, and others. This collaborative process resulted in the Connecticut Guidelines. 
These Guidelines provide recommendations and guidance for the clinical diagnostic 
evaluation of children who may have ASD in the State of Connecticut. The purpose of 
these Guidelines is to provide a consistent and comprehensive source of information for 
diagnosticians who conduct these evaluations. 
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Chapter 1: 
Autism Spectrum Disorder
— 10 — Connecticut Guidelines for a Clinical Diagnosis of Autism Spectrum Disorder
History of Diagnostic Criteria
The earliest and most complete description of what is now called ASD was written by Leo 
Kanner in 1943. Kanner described 11 children who lacked the usual disposition to make social 
contact and had a strong resistance to change in their environment. Kanner called the condition 
“early infantile autism.” Beginning with the third edition of the American Psychiatric Association’s 
Diagnostic and Statistical Manual (DSM-III, 1980), autism was included in the psychiatric manual 
for the first time as a pervasive developmental disorder (PDD). The DSM was revised in 1994 
(APA, 1994) and expanded the number of PDDs to five (autistic disorder, Asperger’s disorder, Rett’s 
disorder, childhood disintegrative disorder, and pervasive developmental disorder, not otherwise 
specified), which were characterized by the triad of core deficits in socialization, communication, 
and restricted and repetitive behaviors. The DSM-IV and the international diagnostic system from 
the World Health Organization, the International Classification of Disorders, tenth edition (ICD-10; 
WHO, 1994) were aligned to ensure a universal definition for the PDDs was used. The DSM-IV was 
updated with a text revision in 2000 (DSM-IV-TR; APA, 2000). 
The work on these guidelines spanned the publication of both the Diagnostic and 
Statistical Manual of Mental Disorders, fourth edition (DSM-IV, APA, 1994) and the Diagnostic 
and Statistical Manual of Mental Disorders, fifth edition (DSM-5, APA, 2013). In preparing the 
Guidelines, the work group determined it was important to present the most recent conceptualization 
and diagnostic criteria, which are now the DSM-5. While the focus of these guidelines is on the 
most recent diagnostic criteria (DSM-5), we are also providing brief descriptions of the DSM-
IV Pervasive Developmental Disorders (PDDs) as well as comparisons between DSM-IV and 
DSM-5 criteria. Since many readers might be familiar with the DSM-IV criteria, we have 
provided two illustrations of the changes that have been made. Table 1 provides a comparative 
summary of the characteristics of the diagnostic criteria for DSM-IV and DSM-5. Appendix 
B, Figure B1 provides a cross-walk of the symptoms contained in the DSM-IV definitions to 
the corresponding symptoms in DSM-5. The DSM-5 and DSM-IV criteria for Autism Spectrum 
Disorder and the Pervasive Developmental Disorders, respectively, are shown in Appendices 
B and C. The criteria in the World Health Organization’s International Classification of 
Disease, tenth edition (ICD-10, 1994) is also in Appendix C.
Description of Current Diagnostic Criteria
The publication of the DSM-5 in May 2013 (APA, 2013) presented major changes to the 
conceptualization of ASD.  Most notably, the term Pervasive Developmental Disorders (PDDs)  was 
replaced with Autism Spectrum Disorder (ASD) and four of the five categorical diagnoses of the 
DSM-IV-TR (autistic disorder, Asperger’s disorder, childhood disintegrative disorder, and pervasive 
developmental disorder, not otherwise specified [PDD-NOS]) were subsumed into one diagnostic 
category (Rett syndrome, which was found to have a unique genetic etiology was retained as a 
specifier, which is a new element of the DSM-5 which is clarified later in this paragraph). Second, 
the triad of symptoms from the DSM-IV-TR (social interaction, communication, and restrictive 
and repetitive behaviors) was reduced to a dyad (social communication and social interaction 
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skills; and restricted, repetitive patterns of behavior, interests, or activities). Among restricted and 
repetitive behaviors, for the first time hyper- or hypo-reactivity to sensory input or unusual interests 
in sensory aspects of the environment was included. Third, the DSM-5 states that criteria (e.g., 
symptoms) can be met currently or by history. The DSM-5 also contains a note that individuals who 
have a well-established DSM-IV diagnosis of autistic disorder, Asperger’s disorder, or PDD-NOS 
should continue to be given the diagnosis of autism spectrum disorder. Fourth, the DSM-5 includes 
specifiers. The specifiers are intended to provide an “opportunity to define a more homogeneous 
subgrouping of individuals with the disorder who share certain features … and to convey information 
that is relevant to the management of the individual’s disorder” (APA, 2013, p. 21-22). The unique 
system of specifiers for ASD includes a functional severity level across a three-level scale (requiring 
support, requiring substantial support, and requiring very substantial support) for both the social 
communication and restricted, repetitive behavior domains. There are also specifiers for the presence 
of accompanying intellectual disability and/or language impairment and associations with other 
known medical or genetic conditions, environmental factors, other neurodevelopmental, mental, or 
behavioral disorders, and catatonia. The specifiers are not mutually exclusive or jointly exhaustive; 
thus more than one specifier can be given (e.g., ASD with intellectual impairment without language 
impairment). In DSM-5, Attention-Deficit/Hyperactivity Disorder (ADHD) is no longer excluded as 
a co-occurring condition, and catatonia is included as a specifier. Finally, a new diagnostic category, 
Social (Pragmatic) Communication Disorder (SCD), was added for individuals who present with 
social deficits in the absence of restricted, repetitive behaviors. 
The DSM-5 criteria are based on extensive research and provide a state of the art 
understanding of the spectrum of functional and pragmatic challenges associated with ASD. This 
understanding includes recognizing that the strengths and needs of those diagnosed with ASD 
represent a continuum. However, these diagnostic criteria were recently published, and have not 
been utilized extensively on a large scale. In order to provide clarity about prior conceptualizations 
of ASD diagnostic criteria, the next section offers this information to serve as a reference when 
reviewing client records.
Pervasive Developmental Disorders of DSM-IV and ICD-10
The following diagnostic criteria provide information for use in the context of DSM-5.
Autistic Disorder 
Autistic disorder (childhood autism in ICD-10) is characterized by impairment in each 
of the three core areas of social interaction, communication and restricted repetitive behaviors. 
The estimated prevalence of autistic disorder is 21/10,000 (Fombonne, 2009). The DSM-IV-TR 
criteria for autistic disorder includes two or more impairments in social interaction, one or more 
impairments in communication, and one or more restricted, repetitive and stereotyped behaviors, 
to total at least six. Prior to age three, delays or impaired skills and functioning should be found 
in at least one of the three areas: social interaction; language as used in social communication; or 
symbolic or imaginative play. 
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Asperger’s Disorder 
Asperger’s disorder (Asperger’s syndrome in ICD-10) is characterized by typical language 
development through age two with deficits in social communication as well as restricted and 
repetitive behaviors. While estimates of the prevalence of Asperger’s disorder are not as robust as 
for the other two disorders on the autism spectrum, due to its more recent inclusion in the DSM, 
Fombonne’s (2009) analysis indicates a prevalence of approximately 6/10,000. The criteria for a 
diagnosis of Asperger’s disorder include children who exhibit at least two behavioral impairment 
items from the social interaction list and at least one from the repetitive and stereotyped behaviors 
list. It is important to be aware that the diagnostic criteria for Asperger’s disorder do not include 
significant delays in language. This is one of the primary differences between autistic disorder as 
compared to Asperger’s disorder. Given that the criteria for Asperger’s disorder include typical 
cognitive and language development in early childhood, the diagnosis is typically made later than 
autistic disorder. In fact, studies have found that children with Asperger’s disorder are diagnosed on 
average between ages 7 and 9, which can be one to three years later than for children with autistic 
disorder and PDD-NOS (Wiggins, Baio, & Rice, 2006; Mandell, Novack, & Zubritsky, 2005; 
Noterdaeme, Springer, & Wriedt, 2008; Williams, Thomas, Sidebotham, & Emond, 2008).
Pervasive Developmental Disorder-Not Otherwise Specified (PDD-NOS)
PDD-NOS (atypical autism in ICD-10) is a diagnosis used when children have significant 
and pervasive deficits in social interaction, and either communication deficits or repetitive and 
stereotyped behaviors but do not meet the threshold set for other PDDs (e.g., autistic disorder, 
Asperger’s disorder). The prevalence of PDD-NOS is estimated to be 37/10,000 people, which 
is nearly twice the rate of autistic disorder (Fombonne, 2009). PDD-NOS is used clinically 
when a child has what a diagnostician considers to be a “mild” form of autism or when the 
onset of symptoms consistent with a pervasive developmental delay occur after age three. 
This diagnosis continues to be ambiguous as the criteria are less prescriptive than those for 
autistic disorder and Asperger’s disorder. However, a recent study found that in a group of 66 
young people with PDD-NOS, 97% had impairments in two of the three core domains of social 
interaction and communication, but no significant repetitive or restrictive behaviors (Mandy, 
Charman, Gilmour, & Skuse, 2011).
Childhood Disintegrative Disorder (CDD) 
CDD is characterized by regression in more than one area of functioning (e.g., motor, social, 
language) after at least two years of typical development. The loss of skills generally occurs 
over the course of several months with developmental regression occurring prior to age 10, but 
typically by the age of five. Children with this disorder display behaviors similar to children 
with autistic disorder, with impairment in social communication skills, and restricted, repetitive 
and stereotyped patterns of behavior. CDD is an extremely rare condition (approximately 
2/100,000; Fombonne, 2009). 
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DSM-IV-TR DSM-5
Diagnostic Classification
Pervasive Developmental Disorders Autism Spectrum Disorder
Number of Diagnostic Categories
• Autistic Disorder
• Asperger’s Disorder
• Rett’s Disorder
• Childhood Disintegrative Disorder
• PDD-NOS
• Autism Spectrum Disorder
Number of Domains
• social interaction
• communication
• restricted, repetitive and stereotyped 
patterns of behavior
• social communication and social 
interaction
• restricted, repetitive patterns of 
behavior
Number of Criteria
• 4 social
• 4 communication
• 4 restricted, repetitive behavior
• 3 social
• 4 restricted, repetitive behavior
Number of Criteria Needed for Diagnosis
Autistic Disorder – 6 criteria
• at least 2 social
• 1 communication
• 1 restricted repetitive behavior
• 2 additional from any category
Asperger’s Disorder - 3 criteria
• at least 2 social
• 1 restricted, repetitive behavior
PDD-NOS – 2 criteria
• at least 1 social 
• 1 from either communication or 
restricted, repetitive behavior
Autism Spectrum Disorder – 5 criteria
• 3 of 3 social communication and 
social interaction 
• 2 of 4 restricted, repetitive behavior
Criteria (symptom) Presentation
• Current • Current or by history
Age By Which Symptoms Must be Present
Delays or abnormal functioning in at 
least one of the following areas, with 
onset prior to age 3 years: (1) social 
interaction, (2) language as used in 
social communication, or (3) symbolic or 
imaginative play.
Symptoms must be present in the 
early developmental period (but may 
not become fully manifest until social 
demands exceed limited capacities, or 
may be masked by learned strategies in 
later life).
Table 1. Comparison of key characteristics of diagnostic criteria for the Pervasive 
Developmental Disorders in DSM-IV-TR and Autism Spectrum Disorder in DSM-5
5
3a
12a
1
2
7
Key: a – for Autistic Disorder and PDD-NOS; Asperger’s Disorder does not contain the communication domain and Rett’s  
Disorder and CDD have unique domains and criteria
Reprinted with permission from the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. © 2000. American Psychiatric Association.
Reprinted with permission from the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. © 2013. American Psychiatric Association.
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Chapter 2 
The Diagnostic Evaluation
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The essential elements of a clinical diagnostic evaluation include a detailed child and 
family/caregiver history, an assessment of the core features of ASD, and a comprehensive medical 
examination to exclude other diagnoses. See Table 7 for a summary of the essential components 
of a diagnostic evaluation. The diagnostician should also consider whether co-occurring disorders 
exist and if genetic testing or a referral for another type of diagnostic evaluation is indicated. It is 
recognized that conducting a high quality and comprehensive evaluation consumes a considerable 
amount of time which may not be commensurate with the level of public/private insurance 
reimbursement. While this document does not address the issue of financial reimbursement for 
diagnosticians, important work remains to be completed in this area. 
Before describing the diagnostic process, we cannot overemphasize the importance of 
using a family-centered approach throughout. A significant portion of the process of diagnosing 
ASD involves listening to and talking with families about their child in order to understand 
the child’s history, current behaviors, strengths, and weaknesses. Therefore it is critical that 
diagnosticians are trained to have a family-centered approach, such that family members/
caregivers are viewed as essential and valuable partners in the process of diagnosing 
children (National Center for Family-Centered Care, 1989). One of the keys to providing 
family-centered care is to recognize that a family consists of those members the family 
chooses to call “family,” thus diagnosticians must be inclusive when asking about and 
involving family members/caregivers in a diagnostic evaluation. This requires flexibility 
on the part of the diagnostician, in terms of scheduling, respecting social and cultural 
values, and building on the strengths of each child and family. Information gathered from 
the family when paired with observations and data gained from thorough assessments, 
contribute to an accurate diagnosis.
Child and Family/Caregiver History
The initial parts of the clinical diagnostic evaluation involve obtaining a comprehensive 
child and family/caregiver history by reviewing medical and other available records, including 
prior evaluations, and interviewing the child’s family/caregiver to understand their concerns 
and to learn about the child’s past and present behavior and functioning. 
Record Review 
The diagnostic clinician should request and obtain medical and other available 
records as part of the diagnostic evaluation process. This can ensure that duplicative tests 
and assessments will not be requested unnecessarily. A thorough record review provides 
information about the child’s diagnostic history, previous diagnoses for the same or different 
presenting symptoms, assessments that may have been conducted and other medical 
assessments that have been completed. It is also important for the diagnostician to know 
whether the child is receiving early intervention or special education services under the 
Individuals with Disabilities Education Improvement Act category of autism (IDEA of 2004, 
34 CFR §300.8 (1)(i)-(iii)) as eligibility for early intervention and special education is different 
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Table 3. Examples of records to be reviewed as part of diagnostic evaluation
MEDICAL RECORDS
Routine well-child care and concerns raised over time
Specialist evaluations by medical specialists and subspecialists (e.g., developmental 
behavioral pediatrician, neurologist, allergist, gastroenterologist, psychologist, 
psychiatrist, geneticist)
Birth records, including results of newborn screening conducted; currently includes 
testing for 41 disorders (Connecticut Department of Public Health, 2012)
Prior hospitalizations
Medical tests that have been completed and reasons the tests were conducted
Medication history (especially use of any psychotropic medications, complementary 
and alternative medications, dosage and child’s response)
Prior medical treatments, including non-traditional therapies
Evidence of neonatal encephalopathy
PRIOR ASSESSMENTS
Developmental evaluations or assessments, including results of any ASD screenings 
and evaluations that have been completed
Other evaluations or assessments (e.g., neuropsychological evaluations, functional 
behavioral assessments, evaluations conducted by speech language pathologists, 
occupational therapists or physical therapists)
EDUCATIONAL RECORDS (E.G., INDIVIDUALIZED FAMILY SERVICE PLANS 
[IFSPS], INDIVIDUALIZED EDUCATION PROGRAMS [IEPS])
Birth to Three and educational evaluations, including those conducted by school 
personnel and related service providers (e.g., occupational therapists, physical 
therapists, speech therapists, school psychologists, social workers) to identify whether 
the child qualifies for early intervention or special education
Current school services and programs, including any specialty program provided by 
the school that the child may attend and the special education disability category 
identified by the child’s Planning and Placement Team (PPT)
Any data related to the child’s educational progress
than a clinical diagnostic assessment for ASD (see Chapter 4 for further reading on this topic). 
Ideally, records are reviewed and integrated prior to the child’s evaluation. Table 3 shows 
examples of records that may be reviewed.
Family Interview
 
Parents are a critical component of the diagnostic process and their perception and 
knowledge of their child’s development should form the basis of the diagnostic process. The 
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diagnostician should gather this information prior to, during, and after the formal assessment in 
order to validate the performance and behavior that is demonstrated by the child. The interview 
should be comprehensive and also conducted in the parent’s primary language in a setting that 
is comfortable for the parents and other family informants. Sample elements of the interview 
are contained in Table 4. 
Table 4. Components of a family interview
COMPONENTS OF A FAMILY INTERVIEW
Reason for the referral and the source of the referral (such as parent, school, or 
primary care physician)
Family concerns, including when the concerns were first raised by the family 
members/caregivers
Preliminary discussion of the family’s/caregiver’s goals for their child
Birth history, including pregnancy, labor, and delivery and neonatal course, if known
Developmental history including when major milestones were reached (e.g., motor, 
communication, social, cognitive, adaptive behavior)
Child’s medical history, including history of any seizures, hearing or visual 
impairments, acquired brain injury, allergies, immunization history. Also includes a 
history of any symptoms that may be associated with ASD, including sleep difficulties, 
unusual diet, self-injurious behaviors, aggression, and anxiety.
Child’s early intervention and educational history, if age appropriate, and the child’s 
response.
Family history (medical, psychosocial), including any history of developmental 
disabilities, including autism, genetic conditions, learning problems, mental health 
and behavioral problems in family members. It is important to learn of family members 
with school problems, alcohol and substance abuse, incarceration and early deaths 
and those who may have had undiagnosed disorders/conditions as well as any 
diagnosed neurological and behavioral problems that family members may have 
experienced. This can be done during the family interview with focused questions 
about family members going back three generations. This discussion is preliminary to 
a clinical genetics testing for Fragile X and chromosome studies, which are indicated 
if the child is found to have ASD (Schaefer, Mendelsohn, & Professional Practice 
Guidelines Committee, 2008). 
Discussion with the family to assess the impact a diagnosis of ASD may have on the 
family, including the family’s ability to accept a diagnosis of ASD, family strengths, 
and the family’s resources.
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Assessment of Core Features
 
The central portion of the evaluation occurs during the visit with the child and family 
and involves the diagnostician observing the child’s behavior in relation to the core features 
of ASD. For some children, especially those under age three who may be enrolled in a 
home visiting or early intervention program, this may occur in the home environment. For 
others it could be a school or clinic setting. No matter where, a comfortable “child friendly” 
environment with developmentally appropriate toys should be created to observe the child at 
play during the assessment. This type of environment allows the diagnostician to get a sense of 
how the child typically interacts with familiar and unfamiliar people. Input from those who know 
the child well may be critical when parents and other key informants find that the observational 
assessment in the diagnostician’s office is not representative of the child’s typical behavior. 
Assessment of Social Interaction and Communication Skills
The diagnostic clinician observes the child’s behavior to assess whether the quality 
and characteristics of the child’s social communication and interaction skills are consistent 
with a diagnosis of ASD. Social communication impairments are characterized by difficulty 
maintaining conversations, deficits in nonverbal communicative behaviors used for social 
Table 5. Signs and symptoms of social interaction and communication skills 
impairments
SIGNS AND SYMPTOMS
Does not respond to name by 12 months of age
Avoids eye-contact 
Primarily prefers to play alone 
Does not share interests with others 
Only interacts to achieve a desired goal 
Has flat or inappropriate facial expressions 
Does not adhere to culturally appropriate personal space boundaries 
Avoids or resists physical contact 
Is not comforted by others during distress 
Uses few or no gestures (e.g., does not wave goodbye)
Does not point or respond to pointing
Appears not to listen to others’ speech
Gives unrelated answers to questions
Uses words in idiosyncratic ways
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interaction, pragmatic issues, such as over-literal understanding of language, and difficulty 
with make-believe play. Social interaction impairments are characterized by an inability or 
disinclination to share and direct attention with another person, called joint attention. Another 
feature of impaired social interaction is a lack of social referencing (e.g., taking cues from 
another’s facial expression in a new situation). Atypical features may be displayed by the signs 
and symptoms shown in Table 5 as adapted from the CDC’s Autism spectrum disorders: Signs 
and symptoms and the DSM-5.
Assessment of Restricted, Repetitive Patterns of Behavior
 
Atypical behaviors in social interaction alone are not sufficient to make a diagnosis 
of ASD. For a child to receive a diagnosis of ASD, they must exhibit two or more restricted, 
repetitive behaviors, interests, or activities, which are the second core feature of ASD. 
Therefore, the diagnostician must observe the child for evidence that the child engages in 
such behaviors that are consistent with ASD. This set of symptoms is exhibited by an apparent 
adherence to routine and discomfort with change, preoccupying interests, and an apparent 
interest in the parts of objects rather than the whole or its functional use (e.g., spinning the tire 
of a toy car, rather than “zooming” the car). It is important to point out that restricted, repetitive 
patterns of behaviors do not emerge and become evident at the same time as the social 
communication and social interaction impairments associated with ASD. Rather, repetitive 
and restricted behaviors typically begin increasing around ages four to five years (Charman 
et al., 2005). Signs and symptoms to help providers and parents identify potential concerns are 
shown in Table 6, as adapted from the CDC Autism spectrum disorders: Signs and symptoms 
and the DSM-5.
Standardized Diagnostic Instruments for Autism
For the majority of children who are evaluated, it may be unclear from the child and 
family history, interview with the family, record review, and observational assessment whether 
a definitive diagnosis of ASD can be made. When a clear clinical picture does not emerge 
from the evaluation, the diagnostic team or lead diagnostician should consider conducting 
a formal assessment using a standardized diagnostic instrument to assess autism symptoms 
or should refer the child and family to an appropriately trained and experienced clinician for 
a diagnostic evaluation. The purpose of the evaluation is to understand behaviors related to 
social interaction, to assess communication skills, and to ascertain whether restricted behaviors 
and repetitive interests are present. Importantly, studies have shown that using the Autism 
Diagnostic and Observation Schedule (ADOS) and the Autism Diagnostic Interview – Revised 
(ADI-R) in combination provided the greatest sensitivity and specificity for the DSM-IV-TR 
criteria (e.g., Risi et al., 2006), which has also been replicated in preliminary examinations of 
DSM-5 criteria (Mazefsky, McPartland, Gastgeb, & Minshew; 2013). 
When selecting an assessment instrument it is important to use those with good 
sensitivity (correctly identifying children who have ASD) and good specificity (correctly 
identifying children who do not have ASD). The selection of particular instruments is based on 
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SIGNS AND SYMPTOMS
Lines up toys or other objects
Plays with toys the same way every time
Appears fascinated with parts of objects (e.g., wheels)
Gets upset by minor changes
Demonstrates preoccupying interests
Indicates a desire to follow certain routines
Flaps hands, rocks body, or spins self in circles
Repeats words or phrases over and over (echolalia)
Engages in self-directed speech by repeating learned ‘scripts’ without directing them 
to others or without apparent communicative intent
Demonstrates hyposensitivity to sensory input (e.g., apparent indifference to pain, 
heat, or cold)
Demonstrates hypersensitivity to sensory input (e.g., covers ears when on a bus, 
always must wear sunglasses, will not wear socks with a seam)
Table 6. Signs and symptoms of restricted, repetitive behaviors
the specific questions about the child’s behavior and development that need to be addressed, 
the age of the child, the child’s presenting characteristics, the experience of the professional(s) 
conducting the testing and other factors related to the particular child. Importantly, the 
instruments discussed in the following section are to be used only with children who have a 
developmental age of at least 12 months. For those with lower developmental ages, conducting 
a developmental assessment with a focus on the core features of ASD, rather than an ASD 
specific assessment might provide better insight into the child’s strengths and challenges. 
Descriptions of sample instruments that could be used to assist in the diagnosis of ASD follow.
Autism Diagnostic Interview-Revised (ADI-R). The ADI-R (Rutter, Le Couteur, & 
Lord, 2003) is a semi-structured diagnostic interview used to assess behaviors related to 
ASD. The ADI-R takes one and a half to two and a half hours to administer and contains 
questions about children’s early development and developmental milestones and focuses 
on three functional domains: language/communication; reciprocal social interactions; and 
restricted, repetitive, and stereotyped behaviors. It is administered by a trained and experienced 
clinician through a formal interview with the child’s caregiver(s). Training on administration 
of the ADI-R can be completed in 16 hours through a DVD series in addition to two hours of 
exercises with experienced clinicians. The ADI-R should be administered for children who 
have a mental age of at least 24 months. A study by Corsello et al. (2007) found that the ADI-R 
has excellent sensitivity (.90) in distinguishing children with ASD from those who do not have 
ASD, however the specificity is lower (.54) in distinguishing these two groups. The algorithm 
used to score the ADI-R distinguishes between children who have DSM-IV-TR autistic disorder 
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from those who do not; it does not diagnose children with PDD-NOS. Although it is likely that 
the ADI-R will continue to have strong reliability and validity when used for DSM-5 criteria, 
revised algorithms are needed before it can be used in clinical practice (e.g., LeCouteur, James, 
Hammal, & McConachie, 2013).
Autism Diagnostic Observation Schedule-2 (ADOS-2). The ADOS-2 (Lord, Luyster, 
Gotham, & Gutherie, 2012) is a standardized observational assessment of ASD that consists 
of five modules, which are selected for administration based on the individual’s age and use 
of speech. The ADOS can be administered to toddlers with a developmental age of 12 months 
through adulthood and to those with limited verbal speech. Through a series of play based 
tasks, the semi-structured instrument enables trained professionals to assess communication, 
social interaction, play and restricted and repetitive behaviors (Lord et al., 2012). The 
assessment takes 40 to 60 minutes to complete. The person administering the ADOS must 
receive 12 to 18 contact hours of training (in person or via video/DVD) or attend an approved  
ADOS-2 workshop. Across the five modules ADOS-2 has good sensitivity (>.80) and 
specificity (> .80) in discriminating autism and PDD from non-spectrum disorders. Scores from 
modules 1, 2 and 3 of the ADOS can be interpreted to indicate the range of concern raised from 
the assessment, across four categories from no evidence of autism spectrum disorder to a high 
level of autism spectrum disorder. The Toddler Module does not produce a score; only ranges 
of concern (little-or-no, mild-to-moderate, moderate-to-severe) result from administering the 
assessment (Luyster et al., 2009). Because the ADOS-2 was developed with the new diagnostic 
criteria in mind, it is not expected that changes to the diagnostic algorithms will be necessary.
Childhood Autism Rating Scale, Second Edition (CARS2). The CARS2 (Schopler, 
Van Bourgondien, Wellman, & Love, 2010) is a behavioral checklist designed to be 
completed by a trained interviewer/observer with children ages two and older. The 
instrument includes three forms: a) CARS2-ST (CARS Standard Version Rating Booklet) 
contains 15 items and is intended for use with individuals younger than 6 years of age and 
those with communication difficulties or those with below-average estimated IQs to assess 
functional areas; b) CARS2-HF (CARS High Functioning Rating Booklet) contains 15 
items and is intended for use with verbally fluent individuals, 6 years of  
age and older, with IQ scores above 80 to assess functional areas; and c) CARS2-QPC 
(CARS Questionnaire for Parents and Caregivers) an unscored caregiver questionnaire. 
The CARS2 can be administered in 5 to 10 minutes, once the information needed to 
complete the assessment is collected. The sensitivity and specificity data as reported by  
the authors of the CARS2 are .81 and .87 respectively.
Social Responsiveness Scale-2. The SRS-2 is a measurement of the severity of autism 
spectrum symptoms as they occur in a child’s natural social settings (Constantino & Gruber, 
2012). The instrument aids in distinguishing autism spectrum conditions from other child 
psychiatric conditions by identifying the presence and extent of autistic social impairment. 
It is administered with children as young as 30 months through adulthood and takes 15 to 20 
minutes to administer. There are multiple versions of the SRS-2 which are administered based 
on the person’s age. There is a Pre School form for children ages 2.5 to 4.5 years and a School 
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Age Form for children four through 18 years. Both of these forms are completed by a parent or 
teacher. Each version contains a total of 65 items which sum to a total score and also include 
five subscales: social awareness; social cognition; social communication; social motivation; 
and restricted interests and repetitive behavior. Research has shown that the sensitivity and 
specificity are above .75 for this instrument (Constantino & Gruber, 2012). The author of the 
SRS-2 has developed two new DSM-5 compatible subscales, based on proposed criteria: Social 
Communication and Interaction and restricted Interests and repetitive behavior. 
Gilliam Autism Rating Scale (GARS-2). The GARS-2 (Gilliam, 2006) is a behavioral 
checklist which consists of 42 items across 3 subscales, a) stereotyped behaviors, b) 
communication, and c) social interaction. Items are posed in three ways, including a 4-point 
Likert scale, parent interview, and open-ended questions. It is designed to be completed 
by parents, teachers, or professionals who are assessing individuals 3 to 22 years of age. 
While there have been no independent studies published on the specificity and sensitivity 
of the GARS-2, the version that preceded the GARS-2 (the GARS), which is very similar 
in content, does not meet recommended levels of specificity and sensitivity. In their review 
of the GARS, Norris and Lecavalier (2010) found the sensitivity of the GARS to be in the 
range of .38 to .53 for four studies, with one study finding a sensitivity of .83 (Norris & 
Lecavalier, 2010). In terms of specificity, a study by Sikora, Hall, Hartley, Gerrard-Morris, 
& Cagle (2008) reported a specificity of .58. It is unclear how well the GARS-2 aligns 
with the DSM-5 criteria.
Additional Standardized Measures When the Diagnosis of ASD is 
Undetermined
After  information is collected from the record reviews, family and child history, and 
the assessment of core features of ASD, it still it may not be clear whether a child should be 
diagnosed with ASD.  In such situations, further use of norm-referenced standardized measures 
that assess various aspects of development may provide additional diagnostic information. 
Although administration of standardized developmental and adaptive measures is not essential 
for a diagnosis of ASD in all cases, such test results may increase diagnostic accuracy and 
confidence and may be required in order to document eligibility for state- or school-based 
services. Therefore, when appropriate, it is recommended that standardized instruments 
be administered to assess the child’s level of development or cognitive ability and current 
adaptive functioning as part of the diagnostic evaluation process. It is therefore important 
that familiarity with instruments that assess developmental and adaptive functioning occurs 
as it is often difficult to obtain a good estimate of cognitive functioning in those with ASD. If 
standardized instruments are not used to assess developmental level or cognitive ability and 
adaptive behavior prior to or during the initial diagnostic evaluation, the diagnostician should 
refer to a qualified professional who can complete cognitive and adaptive testing as part of the 
assessment for intervention planning or to contribute to intervention planning. Examples of 
assessments for developmental domains, adaptive functioning, communication and language 
development, social interaction, and behavior appear in Appendix D. 
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Comprehensive Medical Examination
A comprehensive medical (physical) examination should be performed either during 
the initial evaluation for ASD or the diagnostician should refer the child for a comprehensive 
physical examination soon thereafter. The purpose of the medical examination is to identify 
co-occurring conditions that may require a thorough assessment and to ascertain whether there 
is an underlying etiology that explains the ASD symptoms. Accurately identifying co-occurring 
conditions assists in determining which interventions or treatments are appropriate for the 
child. The medical exam includes the components which follow. Special attention should 
address hearing and other sensory screens. Adaptations of traditional evaluation methods may 
be needed for individuals who lack verbal communication skills or use other alternative forms 
of communication.
• An assessment of height and weight.
• An assessment of head circumference, as macrocephaly (defined as head size 
two standard deviations larger than average for age and gender) develops in 
approximately 20% of individuals with ASD (Fombonne, Roge, Claverie, Courty 
& Fremolle, 1999). A more recent study indicates that boys with regressive autism 
have typical head circumference at birth but an enlarged head by four to six months 
of age (Nordahl et al., 2011).
• A dysmorphology examination to look for developmental anomalies or unusual 
features (facial, limb, stature, etc.). The brief Autism Dysmorphology Measure 
(Miles et al., 2008) has been developed for use by non-dysmorphologists who 
evaluate children with autism.
• An examination of the skin, including Woods lamp examination, to determine 
whether there are hyperpigmented or hypopigmented lesions that may suggest a 
diagnosis of Tuberous sclerosis complex or neurofibromatosis type 1.
• An assessment of motor development and coordination to determine if there is 
evidence of subtle neurological findings or “soft signs,” although the literature 
regarding the validity of these findings is mixed. These soft signs may be exhibited 
by signs such as toe walking early in life, difficulty with rapidly alternating 
movements, or general clumsiness.
• A standardized hearing screening or diagnostic hearing test (e.g., brainstem auditory 
evoked otoacoustic emissions tests) and a full evaluation, if indicated, to determine 
if symptoms are consistent with a hearing loss rather than a social communication 
deficit, or if ASD and hearing loss are co-occurring (Filipek et al., 1999). The 
screening or diagnostic exam should occur even if the child’s newborn hearing 
screening results were normal since acquired hearing loss can occur after birth. This 
is consistent with the Connecticut Birth to Three Autism Guidelines (2011) and 
the Connecticut State Department of Education’s Guidelines for Identification and 
Education of Children and Youth with Autism (2005).
• Vision screening tests performed by the primary care provider to identify any 
impairments, in particular for amblyopia, also known as “lazy eye” (United States 
Connecticut Guidelines for a Clinical Diagnosis of Autism Spectrum Disorder — 25 — 
Preventive Services Task Force, 2011). Examples of tests that might be performed 
include: visual acuity test; stereoacuity test; autorefraction; Hirschberg light reflex 
test; and cover-uncover test. Creedon (2006) suggests additional tests that specialists 
can perform for individuals with autism who need vision screening, including tests 
that do not require verbal communication on the part of the person having the test, 
in such cases, a referral to the appropriate physician should be made.
Associated Medical Conditions
Part of the comprehensive medical exam should include an assessment as to whether 
the child has any associated medical conditions. The way the individual with ASD expresses 
symptoms can make it difficult for the diagnostician to identify a medical or health related 
problem accurately. For example, children with ASD may not indicate pain or discomfort from 
medical problems in the same way as typically developing children. Rather children with ASD 
may display outbursts or self-injurious behavior. Thus, the diagnostician must be thorough in 
reviewing possible co-occurring conditions that are commonly experienced by people with 
ASD. Where needed, the clinician should refer to a specialist for further testing for a more in- 
depth assessment of the cause of symptoms and behaviors.
Seizure disorders. Seizures are caused by abnormal cerebral electrical activity 
that varies in type and duration. Although they may occur at any age, seizures typically 
present in a bimodal fashion, either before 5 years of age or after age 10 (Bolton et al., 2011; 
Minshew, Sweeney, Bauman, & Webb, 2005). Further, seizures may be associated with 
significant language and cognitive impairments. Seizures should be evaluated and treated by 
neurologists. Epilespy is a specific seizure disorder that is a brain disorder characterized by a 
history of at least one seizure and the potential for recurrence of seizures (Fisher et al., 2005). 
An electroencephalogram (EEG) can detect if a person is experiencing seizures and a head 
computed tomography (CT) or magnetic resonance imaging (MRI) may be useful for further 
evaluation. The co-occurrence of epilepsy and ASD is more likely in individuals who also 
have an intellectual disability, and is thought to occur in 20% to 33% of children with ASD 
(Shea & Mesibov, 2005). Landau-Kleffner Syndrome, also known as acquired epileptiform 
aphasia, is an epilepsy syndrome in which a person has typical language development which 
is followed by a progressive loss of receptive and expressive language concomitant with 
abnormal electroencephalography (EEG) findings (Khan & Al Baradie, 2012). Landau-Kleffner 
Syndrome is a considered to be a very rare disorder, although an exact prevalence is unknown 
(Simpson, 2013; Stefanatos, Kinsbourne & Wasserstein, 2002).
Sleep disturbances. This may include insomnia, sleep disordered breathing, or 
parasomnias. Sleep disturbances occur in 50% to 80% of all children with ASD (Reynolds & 
Malow, 2011). Identification of a child’s sleep patterns may warrant a sleep study which can be 
ordered by the pediatrician.
Gastrointestinal disorders. This may include constipation, diarrhea, gastroesophageal 
reflux disease (GERD), or irritable bowel syndrome (IBS). A multidisciplinary panel of experts 
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reviewing evidence gathered to date about ASD and gastrointestinal (GI) symptoms found the 
prevalence of GI symptoms in individuals with ASD unclear, with a range from 9 to 70% (Buie 
et al., 2010). Further, findings indicated that individuals with and without ASD experienced 
similar GI symptoms. The panel concluded that the same workup that is provided to individuals 
without ASD also be provided to individuals with ASD (Buie et al., 2010). Importantly, another 
study did not find statistically significant differences between the overall incidence of GI 
symptoms among individuals with ASD compared to a control group, although children with 
ASD did experience more constipation and more feeding issues/food selectivity (Ibrahim, 
Voigt, Katusic, Weaver, & Barbaresi, 2009).
Feeding/Eating disorders. Children with ASD often have restricted eating 
preferences which may cause nutritional deficiencies. Another feeding/eating problem that is 
found among some children with ASD is pica. Pica is the persistent mouthing of fingers 
or objects, which requires monitoring of blood lead levels, particularly in young children. 
Approximately 10% to 32% of typically developing children between one to six years 
of age experience some form of pica. The literature on the co-occurrence of ASD and 
pica is sparse, however, one study reported that among 70 children with autism, 60% had 
experienced pica behaviors, with the behaviors of nine children considered to be serious 
(Kinnell, 1985).
Laboratory Tests 
A synthesis of the information gathered from the child and family during the medical 
exam will inform which laboratory tests, if any, should be conducted. In some cases, it may be 
possible to determine if there is a known etiology to the presenting symptoms or if multiple 
conditions are evident. Several sets of medical guidelines have been issued by various groups 
including the American Academy of Pediatrics, the American Academy of Neurology, and 
the American College of Medical Genetics describing the laboratory testing that is indicated 
in the evaluation of the child with ASD. The technology to identify small abnormalities in 
the genome is rapidly changing and evolving and the expected yield from diagnostic studies 
is anticipated to increase over time. Following is an overview of current recommended 
laboratory, neuroimaging and other diagnostic tests.
• For children with signs of seizures and for those with language regression, an 
electroencephalography (EEG) is recommended (Miles, McCathren, Stitcher, & 
Shinawi, 2010).
• For children with a head circumference 2.5 times greater than the age appropriate 
mean, phosphatase and tensin homolog (PTEN) gene testing is recommended 
(Schaefer, Mendelson, et al., 2008).
• For some children with specific clinical indicators such as macrocephaly, 
microcephaly, seizures, or an abnormal neurological exam, a brain magnetic 
resonance imaging (MRI) may be indicated (Schaefer, Mendelson, et al., 2008).
• Targeted studies such as metabolic testing should be considered when specific 
symptoms are reported such as cyclic vomiting, or lethargy with minor illness.
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• A recent consensus statement issued by the American College of Medical Genetics 
have recommended that chromosomal microarray should be the first line evaluation 
for children with developmental disability, ASD, and congenital malformations 
due to a higher diagnostic yield excluding those children with recognizable 
chromosomal syndromes, such as Down syndrome (Miller et al., 2010). 
Chromosomal microarray is a genome-wide assay that examines the chromosomes 
for tiny, sub-microscopic deletions or duplications of DNA sequences. Balanced 
rearrangements may not be detected by this methodology (<1% of the time).
Differential Diagnoses and Co-Occurring Conditions
In making a diagnosis of ASD, it is important to distinguish ASD from other 
disorders that may present similarly. The DSM-5 (APA, 2013) provides specific guidance 
on such differential diagnosis between ASD and Rett syndrome, Selective Mutism, 
Language Disorder and Social (Pragmatic) Communication Disorder, Intellectual 
Disability, stereotypic movement disorder, Attention-Deficit/Hyperactivity Disorder, 
and Schizophrenia. In addition to the medical conditions that can co-occur with ASD, 
it is important to understand that having ASD does not preclude a child from having 
additional co-occurring conditions, including some conditions from which ASD must 
be differentiated. In fact, individuals with ASD often experience conditions that are 
associated with ASD and may have a higher rate than the typical population for some 
conditions (Bolton, 2009; Levy et al., 2010). It can also be useful to understand if an 
etiological factor is present. Information on differential disorders, co-occurring conditions, 
environmental factors, and etiological factors follow and these are listed on Table 8.
Neurodevelopmental Disorders
Attention-Deficit/Hyperactivity Disorder (ADHD). Attention-Deficit/Hyperactivity 
Disorder (ADHD) is characterized by inattention, hyperactivity, and/or impulsivity that 
interfere with a person’s functioning or development (APA, 2013). While social difficulties 
can be present in children with ADHD without ASD, the social impairment difficulties 
seen in ADHD are related primarily to impulsivity and executive functioning challenges  
of the disorder, not from the primary social and communication deficits seen in ASD. 
While the DSM-IV did not permit the diagnosis of ASD to be co-occurring with ADHD, 
this has been reversed in DSM-5 and ADHD can now be used as a specifier for ASD. 
Because inattention, hyperactivity, and impusivity can all be symptoms of ASD, ADHD 
should only be used as a specifier “when attentional difficulties or hyperactivity exceeds 
that typically seen in individuals of comparable mental age,” (APA, 2013, p. 58). The 
prevalence of ADHD is estimated to be about 8% (American Academy of Pediatrics, 2011) 
with up to 40% of children with ASD also having symptoms of ADHD (Zeiner, Gievik, & 
Weidle, 2011). 
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Intellectual Disability. Intellectual disability (formerly referred to as mental retardation) 
is characterized by deficits in intellectual (cognitive) functioning as well as deficits in adaptive 
functioning, including conceptual, practical and social skills that are manifested during the 
developmental period. The common features of ASD and intellectual disability include lack of 
visual or auditory responses, lack of language and motor delays, behavior problems, and limitations 
in adaptive behaviors (APA, 2013). Although children with intellectual disability may show 
social-communicative deficits, these skills are commensurate with their cognitive level whereas in 
children with ASD there is a discrepancy between an individual’s social competence and cognitive 
abilities. The prevalence of intellectual disability is estimated to be about 1% (Maulik, Mascarenhas, 
Mathers, Dua, & Saxena, 2011), with up to 50% of people with ASD also having an intellectual 
disability or global developmental delay (Johnson & Myers, 2007; CDC, 2012a).
Language Disorder. Language Disorder is characterized by difficulties in acquiring 
and using language because of impairments in comprehension or production of language (APA, 
2013). Communication difficulties are also seen in children with ASD and Language Disorder, 
and as described in DSM-5 (APA, 2013), can co-occur with ASD. Children who have Language 
Disorder without ASD may have social interaction problems because of their difficulties in 
understanding or using language, but do not show restricted interests and repetitive behaviors. 
The prevalence of language disorders in children without ASD has been estimated to be about 
6% (Law, Boyle, Harris, Harkness, & Nye, 2000). 
Social (Pragmatic) Communication Disorder (SCD). SCD is a new diagnostic 
classification in the DSM-5 (APA, 2013) and describes a communication disorder in which 
individuals with social aspects of language such as initiating conversation (talking too much 
or to everyone), maintaining coherence, following rules of conversation and storytelling, 
understanding and matching context, and understanding communicative intent that is not 
explicitly stated. The onset of symptoms must occur in the early developmental period, 
although symptoms might not become fully manifested until social demands exceed limited 
capacities and cannot be attributed to another medical or neurological condition (including 
ASD, intellectual disability, or ADHD) or to low abilities in the domains of word structure and 
grammar. SCD cannot co-occur with ASD. These symptoms occur in the absence of restricted, 
repetitive patterns of behavior, which differentiates SCD from ASD. Because it is a new 
disorder, estimates of the prevalence cannot be made at this time.
Stereotypic Movement Disorder. Stereotypic Movement Disorder is characterized by 
repetitive movements with onset in the developmental period that appear to lack a purpose 
(e.g., arm flapping, head banging), might cause bodily harm, and interfere with everyday 
functioning (APA, 2013). Both individuals with Stereotypic Movement Disorder as well as 
those with ASD may have repetitive behaviors, such as rocking, hand shaking or waving, 
and head banging. However, those with Stereotypic Movement Disorder alone do not have 
the social interaction and communication deficits that are characteristic of ASD. Stereotypic 
Movement Disorder can co-occur with ASD but is only diagnosed in ASD when there is self-
injurious behavior (APA, 2013). An estimated 7% of children have Stereotypic Movement 
Disorder (Zinner & Mink, 2010). 
Connecticut Guidelines for a Clinical Diagnosis of Autism Spectrum Disorder — 29 — 
Tourette’s disorder. Tourette’s disorder is a tic disorder, that is characterized by motor 
and vocal tics that may occur simultaneously or at different times with onset prior to age 18 
(APA, 2013). Repetitive, stereotypic movements or vocalizations are one of the core features 
of Tourette’s disorder that may also be exhibited by individuals with ASD, however, onset of 
Tourette’s disorder is typically after a child is six-years-old (Burnette & Singer, 2007) and the 
social interaction deficits characteristic of ASD are not found in individuals with Tourette’s 
disorder. The prevalence of a lifetime diagnosis of Tourette’s disorder has been estimated at 
less than 1% of children (Scahill, Bitsko, & Blumberg, 2009).
Mental/Behavioral Disorders
Anxiety disorders. Anxiety disorders are characterized by persistent and “excessive 
fear and anxiety and related behavioral disturbances” (APA, 2013, p. 189). Children with 
anxiety disorders who do not have ASD are avoidant in particular situations, but capably 
display social interaction and communication skills among people with whom they are familiar. 
This is in contrast to children with ASD who, although they often have differential patterns of 
responses depending on the setting, will display atypical patterns in all social interactions. Data 
on the prevalence of anxiety disorders for adolescent-aged children is estimated to be about 
13% (Costello et al., 1996) and the co-occurrence of anxiety and ASD has been shown to be 
about 40% (Siminoff et al., 2008).
Depressive disorders. Depressive disorders in children (ages 6 to 12 years) may be 
characterized by irritability, anxiety, sleeping and behavior problems, whereas adolescents 
(ages 13 to 18 years) may express feelings of hopelessness and guilt (Birmaher et al., 2007). 
Distinguishing between children who are depressed and children who have ASD requires an 
assessment as to whether symptoms such as social withdrawal are the result of general sadness 
that is experienced by the child (depression) or the result of a deficit in social communication 
skills (ASD). The prevalence of depression in children (ages 6 to 12 years) is estimated to be 
2% and in adolescents (ages 13 to 18 years) between 4 to 8% (Birmaher et al., 2007). The rate 
of depression in individuals with ASD has been estimated to be between 2 to 38% (Magnuson 
& Constantino, 2011), with the highest co-occurrence seen in individuals who are considered 
higher-functioning.
Obsessive Compulsive Disorders (OCD). OCD are characterized by obsessions 
or compulsions that take up a considerable part of an individual’s day or cause significant 
distress or impairment (APA, 2013). The diagnostician must determine whether the presenting 
symptoms are consistent with obsessions and compulsions and thus are indicative of OCD or 
whether they are restricted and repetitive interests, behaviors, or activities that are consistent 
with the core features of ASD. In children with OCD alone, impairments in social interactions 
and communication are usually not present, whereas these two areas are impaired in children 
with ASD. Estimates of prevalence of OCD are about 1% in children and up to 2% of 
adolescents (Flament et al., 1988). Studies have shown 2% to 81% of children with ASD have 
a co-existing diagnosis of OCD (Leyfer et al., 2006).
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Oppositional Defiant Disorder (ODD) and Conduct Disorders (CD). ODD is 
characterized by “a pattern of angry/irritable mood, argumentative/defiant behavior, or 
vindictiveness” which may include losing one’s temper, arguing with adults, refusing to 
comply with requests or rules, often being angry, resentful or vindictive (APA, 2013, p. 462). 
CD is considered to be more severe in that the rights of others or major social norms are 
violated through aggression, property destruction, deceitfulness or theft, or serious rule 
violations (APA, 2013). Common overlapping behaviors among people with ODD, CD and 
ASD include difficulties with social interactions, but children with ODD and CD without 
ASD often do not present the restrictive and repetitive behaviors associated with ASD. 
The prevalence of an individual having ODD over a lifetime is estimated at 10%, based 
on retrospective self-report (Nock, Kazdin, Hiripi, & Kessler, 2007). The co-occurrence 
of ODD symptoms among children with ASD has been estimated to 13% to 26% (Gadow, 
DeVincent, & Drabick, 2008). 
Personality disorders. Personality disorders are described as “an enduring pattern of 
inner experience and behavior that deviates markedly from the expectations of the individual’s 
culture” (APA, 2013, p. 646). Both people with personality disorders and those with ASD have 
behavior problems that interfere with their relationships. Individuals with personality disorders 
such as schizoid and schizotypal personality disorders have difficulties with social interactions 
but do not have communication impairments or repetitive behaviors, which are evident in 
individuals with ASD. The lifetime prevalence of personality disorders is estimated to be 9% 
(Lenzenweger, Lane, Loranger, & Kessler, 2007).
Reactive Attachment Disorder (RAD). Reactive Attachment Disorder is used to 
describe children who have not developed appropriate attachment behaviors related to 
comfort, support, protection, and nurturance, often due to neglect, abuse, or an otherwise 
unstable caregiving environment (APA, 2013). Children with Reactive Attachment 
Disorder may present with disinhibited social interactions and indiscriminate sociability 
that is disproportionate to the relationship, which is also seen in ASD. The differential 
features between Reactive Attachment Disorder and ASD include a history of neglect 
and the absence of restricted and repetitive behaviors. Reactive Attachment Disorder 
cannot co-occur with ASD. Prevalence of Reactive Attachment Disorder is not known but 
considered to be very rare (APA, 2013).
Schizophrenia. Schizophrenia is characterized by the presence of delusions, 
hallucinations, disorganized speech, disorganized or catatonic behavior, and negative 
symptoms (APA, 2013). Behaviors that are common between Schizophrenia and ASD 
include social isolation, idiosyncratic preoccupations, and flat affect. Schizophrenia can be 
distinguished from ASD in that individuals with Schizophrenia exhibit paranoid ideation 
(belief that one is being harassed or persecuted, having suspicions of others’ motives), 
which is not usually present in individuals with ASD, and onset of Schizophrenia typically 
does not occur until adolescence or early adulthood. The lifetime prevalence is estimated 
to be less than 1% (APA, 2013).
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Selective Mutism. Selective Mutism describes a disorder in which a person does not 
communicate in particular settings, but exhibits intact communication skills in other settings 
(APA, 2013). Onset of Selective Mutism typically occurs before age five but may not be 
recognized until the child begins school. Selective Mutism is often accompanied by excessive 
shyness and fear of social embarrassment, which may present as atypical or withdrawn social 
interaction. In comparison, children with ASD may not communicate because of the core 
features of the disorder, which may pervade all interactions, not particular ones as in Selective 
Mutism. Another distinguishing factor is that children with Selective Mutism do not have 
restricted or repetitive behaviors. The prevalence of Selective Mutism is thought to be between 
1- and 2% (Viana, Beidel, & Rabian, 2009).
Genetic Etiologic Factors of ASD
Angelman syndrome. Communication deficits, hand-flapping, motor hyperactivity, 
sudden bursts of laughter, seizures, facial dysmorphology, and intellectual disability are core 
features of Angelman syndrome (Cohen et al., 2005). Children with Angelman syndrome 
enjoy being around other people and demonstrate a desire to communicate with others 
and display this in a variety of ways including the use of non-verbal gestures. Angelman 
syndrome is caused by the deletion of the maternally derived UBE3A, gene which is located 
on chromosome 15. Approximately 80 to 100% of people with Angelman syndrome also have 
ASD and 1% of people with ASD have Angelman syndrome (Cohen et al., 2005). 
Cornelia deLange sydrome. Individuals with Cornelia deLange are typically of 
small stature, have limb abnormalities, and have facial dsymorphology. They may be 
hypersensitive, impulsive, exhibit self-injurious, aggressive and compulsive behavior, 
have expressive communication and cognitive deficits (Oliver, Arron, Sloneem, & Hall, 
2008). Cornelia deLange syndrome is caused by a mutation in the Nipped-B-like gene 
(NIPBL) gene, which is linked to chromosome 3q26.3. The physical characteristics 
of Cornelia deLange syndrome are not present in individuals with ASD, which is how 
the two conditions are differentiated. The prevalence of Cornelia deLange syndrome 
is approximately 1 in 10,000 to1/100,000 (Simpson, 2013). The co-occurrence of ASD 
among individuals with Cornelia deLange syndrome is estimated between 32% and 62% 
(Berney, Ireland & Burn, 1999; Oliver et al., 2008; Moss et al., 2008).
Down syndrome. Down syndrome, also known as trisomy 21, is a genetic disorder 
characterized by intellectual disability, language delays, characteristic facial features and 
weak muscle tone, with increased risk for a variety of medical conditions (Roizen, 2013). 
Chromosomal analysis can reveal whether a child has Down syndrome, which is caused 
by the presence of all or part of a third copy of chromosome 21. The prevalence of Down 
syndrome is about 12/10,000 (Roizen, 2013). Reports of the number of people who have 
Down syndrome and also have ASD range from 5 to 39% (Moss, Richards, Nelson & Oliver, 
2012) and the number of people with ASD who also have Down syndrome ranges from 0% to 
17% (Filipek, 2005).
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Fragile X syndrome. Fragile X is an inherited disorder and the most commonly known 
inherited cause of intellectual disability characterized by poor eye contact, hand flapping and 
biting, attention deficits, anxiety, social avoidance, and language delays (Abrams et al., 2011). 
Mild facial dysmorphology (e.g., long face, large ears, and macroorchidism) is also present in 
Fragile X. Fragile X is caused by expansion of the CGG trinucleotide repeats and the effect of this 
is a reduction or elimination of the FMR1 (Fragile X gene) protein. It is estimated that 2.5/10,000 
males and 1.25/10,000 females are born with the full mutation for Fragile X (Batshaw, Gropman, 
& Lanpher, 2013). Approximately 15 to 20% of people with ASD also have Fragile X (Schaefer, 
Mendelson, et al., 2008) and the co-occurrence of ASD with Fragile X in pre-mutation and full 
mutation males and females is approximately 35% (Bailey, Raspa, Olmsted, & Holiday, 2008).
Prader-Willi syndrome. Some of the features characteristic of Prader-Willi syndrome 
include speech delays, intellectual disability, repetitive and obsessive behaviors and self-
injurious behaviors in addition to an insatiable appetite and obesity beginning in childhood 
when not controlled (Veltman, Craig, & Bolton, 2005). A deletion on part of chromosome 15 is 
the cause of Prader-Willi syndrome: either a deletion of 15q11-q13 on the maternally inherited 
chromosome, a paternal inheritance of both copies of chromosome 15, or a point mutation in 
the maternal copy of the UBE3A gene. Typically individuals with Prader-Willi syndrome have 
distinctive facial dysmorphology, which is not present in those with ASD, nor do individuals 
with ASD have the difficulties during infancy with growth and feeding followed by insatiable 
appetite as they develop through childhood. Prevalence is estimated at 1/10,000 to 1 in 15,000, 
of which 25% also have ASD (Veltman et al., 2005).
Rett syndrome. Rett syndrome is a condition found nearly exclusively among females 
and is characterized by typical development very early in life followed by a loss or slowing 
down of development (APA, 1994). Rett syndrome is caused by a genetic mutation to the 
methyl-CpG binding protein 2 (MeCP2) gene at Xq28. Stereotypic movements (e.g., hand 
wringing), intellectual impairment, and motor difficulties are some of the characteristics of Rett 
syndrome (Van Acker, Loncola & Van Acker, 2005). Early symptoms of Rett syndrome such 
as language loss and reduced social engagement may initially suggest a diagnosis of ASD, but 
Rett syndrome can be distinguished by decreasing head growth, hand wringing stereotypies 
and progressive gait disturbance. If an individual presents symptoms consistent with the DSM-
5 diagnostic criteria for ASD and Rett syndrome, the ASD diagnosis should be given, adding 
Rett syndrome as a specifier of a known genetic condition (e.g., autism spectrum disorder with Rett 
syndrome). It is estimated that 1/10,000-20,000 girls have Rett syndrome (Van Acker et al., 2005). 
Tuberous sclerosis complex (TSC). TSC is a neurological condition characterized by 
lesions throughout several organs, such as the heart, liver, lungs and skin and ash leaf-shaped 
depigmented skin spots or macules and facial angiofribromas (Simpson, 2013; Sheehan, 2010). 
TSC is caused by a defect in the TSC1 or TSC2 gene that codes for a protein called tuberin. 
People with TSC may have stereotypies, as well as social and communication deficits common 
in individuals with ASD, and it is estimated that up to 60% of individuals with tuberous 
sclerosis have ASD (Curatolo, Porfirio, Manzi, & Seri, 2004). Estimates suggest that 1-4% of 
people with ASD also have Tuberous sclerosis (Hyman & Towbin, 2007). 
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Williams syndrome. Common traits of Williams syndrome are intellectual disability, 
communication delay in early childhood, extroverted personality, disinhibition in social 
interactions, and characteristic physical features (Simpson, 2013; Kaufmann, Capone, Carter 
& Lieberman, 2008). A combination of medical tests can be used to determine if a person has 
Williams syndrome (blood pressure, blood test, echocardiogram and Doppler ultrasound, and 
kidney ultrasound). Williams syndrome is the result of a deletion of the 7q11.23 region of 
chromosome 7 which contains the elastin gene. It is estimated that the prevalence of Williams 
syndrome is 1/7,500 to 1/20,000 (Simpson, 2013) and has been reported to co-occur with ASD 
in a small number of case studies (see Tordjman et al., 2012).
Environmental Factors
Fetal alcohol spectrum disorder. Characteristics of fetal alcohol spectrum disorder are 
delayed development, deficits in executive functioning, impaired social skills and difficulties 
with adaptive skills (Pei, Job, Kully-Marten & Rasmussen, 2011). Children with fetal alcohol 
spectrum disorder often have difficulty reading social cues, have poor social judgment and 
can be indiscriminate in their social approach such that their social behaviors appear atypical 
(Wyper & Rasmussen, 2011). Children with the full manifestations of fetal alcohol syndrome 
will have, in addition to current or past growth abnormalities and functional impairment 
in neurodevelopment, the hallmark facial abnormalities, including small palpebral fissures 
(smaller eye openings), a smooth and often elongated philtrum (an underdeveloped groove 
between the nose and the upper lip) and a thin upper lip; children with ASD alone do not have 
these dysmorphic characteristics. Generally, it is reported that up to 30/10,000 infants are born 
with a pattern of physical, developmental, and functional problems indicative of fetal alcohol 
spectrum disorder (Chudley et al., 2005).
Phenylketonuria (PKU).  Infants born with PKU appear typically developing at birth, 
but soon thereafter have difficulty feeding, and may experience vomiting and appear irritable 
(Clements, 2010). If the condition goes undetected and untreated, infants will not have an 
increase in head circumference and they will have spasms and abnormal EEG findings. Severe 
intellectual disability will result (Clements, 2010). PKU has been known both as a cause of 
ASD as well as a co-occurring condition. If identified at an early age, PKU can be treated and 
controlled with diet. The prevalence of PKU has been estimated to be 1/25,000 (American 
College of Medical Genetics, 2005), with early estimates of the co-occurrence of PKU and 
ASD at about 5% (Baieli, Pavone, Meli, Fiumara, & Coleman, 2003). 
Other Conditions
Blind or visual impairment. Blindness is “visual acuity of 20/200 or worse in the 
better eye with correction, or a visual field that subtends to an angle of not greater than 20 
degrees instead of the usual 105 degrees” (Geddie, Bina, & Miller, 2013, p. 182). Features 
indicative of untreated visual impairment in young children include abnormal movement of the 
eyes, eyes that look in only one direction, eyes that do not react to stimuli or habitual pressing 
of the eyes (Geddie et al., 2013). ASD is the most common developmental disorder among 
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children who are blind with estimates of 31% of children with limited or no functional vision 
also having ASD (Parr, Dale, Shaffer, & Salt, 2010). 
Deaf or hard of hearing. Those who are deaf or hard of hearing experience loss of 
hearing that may be mild, moderate, severe or profound and may be temporary or permanent 
(Buethe, Vohr, & Herer, 2013). Features of hearing loss in an infant include not awakening 
in reaction to loud noises and reduced, delayed or absent babbling by six months and later 
poor speech intelligibility (Buethe et al., 2013). Children with hearing loss may appear to be 
uninterested in social interactions or have limited social skills due to an inability to attend to 
what is being said. This is in contrast to children with ASD, who demonstrate impairments 
in social interaction and communication, often showing little or atypical interest in social 
interaction. Approximately 14/10,000 babies in the U. S. are born each year with hearing loss 
(CDC, 2012b), with profound deafness occurring in 4-11/10,000 school aged children. There 
is a higher than expected prevalence of ASD among children with hearing impairment (2%; 
Szymanski, Brice, Lam, & Hotto, 2012), and it is estimated that about 8% of children with ASD 
have mild to moderate hearing loss (Rosenhall, Nordin, Sandstrom, Ahlsen, & Gillberg, 1999).
 
Mitochondrial disorders.  Mitochondrial disorders describe disorders that are caused 
by abnormal functioning of the mitochondria (energy producers of the cell) or mitochondrial 
metabolism. The diverse group of disorders often shares several features: drooping eyelid 
(ptosis), short stature, paralysis of external eye muscles and hypothyroidism (Simpson, 2013, 
p. 783). A review of studies looking at ASD and mitochondrial disease found that there are 
common characteristics among children with ASD that may indicate a need for further testing 
to determine if mitochondrial disease is co-occurring. Mitochondrial disorders are estimated 
to affect approximately 5/10,000 (Schaefer, McFarland, et al., 2008). Children with ASD with 
a history of regression and multi-organ system involvement have been shown to be at greatest 
risk for a co-occurring mitochondrial disorder (Haas, 2010). 
Regulation disorders of sensory processing. Regulation disorders of sensory 
processing are exhibited by unusual reactions to sensory stimulation (e.g., an unusually high 
threshold for pain, high sensitivity to auditory and visual stimulation, odors, or textures; Zero 
to Three, 2005). Sensory features are commonly described as hyper-responsiveness, hypo-
responsiveness, and sensory seeking (Baranek, 2002; Ben-Sasson et al., 2008; Liss, Saulnier, 
Fein, & Kisbourne, 2006). Brock et al. (2012) report a high prevalence of both hyper- and hypo-
responsiveness in ASD, sometimes in the same child. Children who have regulation disorders of 
sensory processing without ASD will not exhibit the social communication difficulties that are a 
core feature of ASDs. Hyper- or hypo-responsiveness to sensory input or unusual interest in sensory 
aspects of the environment was added as a diagnostic symptom in DSM-5, but is not required for 
a diagnosis of ASD (2 of 4 restricted, repetitive behaviors are necessary, of which one can be the 
sensory symptom). Approximately 10 to 17% of children without ASD are over responsive to 
sensory input (Green, Ben-Sasson, Soto, & Carter, 2011), and estimates of sensory over responsivity 
in ASD have been estimated to be as high as 90% (Gomot & Wicker, 2011).
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Additional Considerations for the Diagnostic Evaluation
When conducting a diagnostic evaluation, there are additional considerations that 
should be taken into consideration, both in regard to the child and the diagnostician.
Considerations for Children
Very young children. The evaluation of very young children, those less than 24 months 
old, presents particular challenges for diagnosticians and families, as these children display 
symptoms that may be more subtle and more difficult to distinguish from other developmental 
delays or even typical development (Zwaigenbaum et al., 2005; Rogers, 2009). When giving 
a diagnosis to a very young child, a follow-up evaluation may be needed, as the stability of 
early diagnoses have shown some individuals might not meet diagnostic criteria later in life 
(Zwaigenbaum, et al., 2009). Research conducted prior to the official release of the DSM-5 
indicates that the DSM-5 criteria for ASD may be more difficult to meet than were the criteria 
under the DSM-IV for young children (Barton, Robins, Jashar, Brennan, & Fein, 2013; Worley 
& Matson, 2012). It will be important to track the implications of the new criteria on the 
diagnosis of young children.
Older children, adolescents, and adults. There are some school age children who 
perform well academically and therefore may not come to the attention of their teachers or 
parents. Some of these children may display social communication problems, experience 
social isolation, loneliness, be rejected socially by their peers, and/or have highly intense 
preoccupying interests. There are some older children, more specifically, adolescents, who may 
come to the attention of professionals when they experience significant anxiety or depression 
related to unsuccessful attempts at social engagement. It is recommended that these children 
have a clinical diagnostic evaluation. The signs and symptoms exhibited by children ages 11 
and older can be found in Appendix E.
Child’s gender. The prevalence of ASD in girls is one fourth the rate experienced by 
boys in the US (CDC, 2012a). In fact, research has found that even when symptoms are equally 
severe, boys are more likely to be identified with ASD than girls (Russell, Steer, & Golding, 
2011). There is evidence to indicate that among children up to age eight, girls are diagnosed 
later than boys (6.1 years for girls and 5.6 years for boys; Shattuck et al., 2009). Therefore it is 
important that families and diagnosticians not rule out ASD as a possibility simply because the 
child is female. 
Child’s race and ethnicity. Reports of disparities in the rates of diagnosis of children 
by race and ethnicity in the United States show that Black and Hispanic children are diagnosed 
at a lower rate than White, non-Hispanic children (CDC, 2012a). Data from Connecticut’s 
Birth to Three System and the Connecticut State Department of Education mirror the state’s 
racial and ethnic population overall, indicating no disparities in the identification of children 
with ASD who receive early intervention services through Birth to Three and supports and 
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services through special education (Connecticut State Department of Education, personal 
communication, May 11, 2012). It is not possible from Connecticut’s data to determine whether 
clinical diagnostic data are also proportional. Therefore, it is critical that parents, providers 
and educators remain vigilant in ensuring that all children, regardless of race, ethnicity or 
socioeconomic status are diagnosed early and provided with the individualized services that 
will result in optimal outcomes.
Child’s language. Disparities in accessing medical care are generally found when 
families speak a language other than English. Providers can support families by ensuring access to 
professional interpreter services (e.g., Language Line Services). Further, careful attention should be 
paid to children who are English language learners as professionals may make assumptions about a 
child’s communication abilities because English is the child’s second language.
Considerations for the Diagnostician
Knowledge and skills. Diagnosing ASD in children is challenging. Currently, there 
are no medical tests or procedures to definitively diagnose this complex neurodevelopmental 
disorder. As previously stated, ASD is characterized by a heterogeneous group of behaviors of 
varying severity, causing varying types and degrees of impairment. In addition, the research 
over the past several decades has evolved in its understanding of the core features of the 
disorder, how the disorder is expressed, and when the core features are first expressed (Karmel 
et al., 2010). These factors make it essential that clinicians acquire sufficient training and 
experience with children diagnosed with ASD, and the current diagnostic systems in use. 
Lastly, diagnosticians must also be knowledgeable of the systems of services and supports 
available to children with ASD and their families. Diagnosticians may need to refer a child 
to appropriate programs and services for interventions that are evidence-based, and to refer 
families to available family and medical support services. 
A diagnostic evaluation may be conducted independently by a clinician or by a 
multidisciplinary team that could include to a developmental behavioral pediatrician, a 
neurologist, a psychiatrist, a psychologist, an advanced practice registered nurse, a clinical 
social worker, a speech-language pathologist, an occupational therapist, a physical therapist, 
a board certified behavior analyst, or an educator/special educator, or any combination. 
Importantly, if the diagnostic evaluation is conducted by one clinician, it must be within the 
scope of his or her practice. Regardless of the diagnostician’s discipline, it is critical that the 
professional conducting the evaluation has extensive experience evaluating children with 
developmental disabilities and specifically children with ASD. That experience should include 
didactic learning regarding ASD, familiarity with methods and instruments to diagnose ASD, 
repeated opportunities to screen and evaluate a broad range of children with ASD, and training 
by professionals in the field as described below. 
According to CT state statute (Conn. Gen. Stat. § 38a-514b, see Text Box 1, page 
39), families with children who are diagnosed by a licensed physician, psychologist or and 
clinical social worker may seek to use their insurance to pay for autism services; other types 
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of professionals may not diagnose autism if the family wants to bill insurance for services. 
This requirement does not apply for families enrolled in employer funded self-insured plans, to 
families with children enrolled in Connecticut’s Medicaid program called HUSKY A (Health 
insurance program for UninSured Kids and Youth), nor to families who choose to pay for ASD 
services out of pocket. Notably, the three types professionals listed are not the only clinicians 
who are competent to diagnose a child accurately.
Didactic and continuous learning. Didactic learning is critical in understanding 
the core features of ASD, in assessing its manifestations and in differentiating it from other 
conditions. Diagnosticians must also remain abreast of the rapidly expanding literature on 
ASD. To remain proficient in the field, diagnosticians must be lifelong learners who view 
ongoing professional development as a critical component in the provision of evidence based 
care to children and families in a markedly changing field.  Diagnosticians must also be 
familiar with recommendations provided by national groups related to ASD. For example, 
the AAP has published recommendations on identifying and evaluating children with ASD 
that provides a detailed surveillance and screening algorithm with which all diagnosticians 
should be familiar (Johnson & Myers, 2007 and reaffirmed 2010). The algorithm is included in 
Appendix A. 
Exposure to standardized instruments. There are a number of standardized 
instruments that can be useful in determining whether a child has ASD and a list of some 
of these instruments is provided in the section on Standardized Diagnostic Instruments for 
Autism. Again, it is expected that a professional would become familiar with these instruments 
as they assist in collecting information about a child’s symptoms and behaviors using a 
standardized methodology. As stated earlier, research has shown that using standardized 
behavioral observation instruments increases diagnostic accuracy in clinical settings (Risi et 
al., 2006; Mazefsky, et al., 2013). If the diagnostician finds that a standardized observation 
instrument is indicated, a diagnostic instrument with good sensitivity (appropriately identifies 
children who have ASD as having ASD) and good specificity (appropriately identifies children 
who do not have ASD as not having ASD) should be selected, appropriate to the child’s age. 
Instruments should be administered in accordance with the publisher’s instructions and the 
diagnostician must meet the training requirements set forth by the publisher of the specific 
instrument being used to ensure optimal validity. 
Repeated opportunities to evaluate children with ASD. Recognizing and identifying 
the core features of ASD is achieved by assessing sufficient numbers of children with and 
without ASD to develop an understanding of the wide spectrum of the disorder. Research 
suggests that more experienced clinicians make more accurate diagnostic decisions than 
clinicians with less experience (Volkmar et al., 1994). Multiple opportunities to observe the 
signs and symptoms of the disorder are needed to diagnose ASD, and this should be done under 
the supervision of and mentoring by clinicians with significant experience diagnosing ASD.  
The supervisor/mentor should provide a trainee with a considerable number of opportunities to 
evaluate infants, children and adolescents who display the range of behaviors and symptoms 
indicative of ASD.  Further, trainees should gain exposure to various types of interventions that 
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children with ASD receive and the settings in which the services occur (e.g. home, child care, 
public school, private practice). Finally, the training should also encompass the principles of 
family-centered care and medical home to ensure that recommended follow-up for the child is 
appropriately accessible by families and coordinated.
A Note about Use of Clinical Judgment
In cases where a diagnosis of ASD is unambiguous, seasoned diagnosticians may rely 
upon their own clinical judgment based on current diagnostic criteria (Fein, 2010). While it 
may be appropriate to use clinical judgment solely to diagnose ASD, a professional’s use of 
clinical judgment does not exempt the diagnostician from preparing a comprehensive report 
documenting how a child’s presenting symptoms, behavior and history are consistent with a 
diagnosis of ASD. This includes a detailed discussion of how the child is displaying the core 
symptoms of ASD.
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Text Box 1: Connecticut Health Insurance Legislation
Connecticut’s Health Insurance Coverage for Autism Spectrum Disorders Act of 
2009 (Conn. Gen. Stat. § 38a-514b) states that insurance coverage for autism spectrum 
disorder services is provided when diagnosticians with state licensure as a physician, 
psychologist, or clinical social worker render a diagnosis of an ASD, based on the most 
recent edition of the American Psychological Association’s DSM. This means that if a 
family is seeking to use their insurance to pay for autism services for children up to age 
15, excluding services offered in public schools, the child must have a clinical diagnosis 
of autism (not just educational eligibility) and it must have been given by one of the 
types of diagnosticians listed above. The coverage for ASD does not apply to families 
enrolled in employer funded self-insured plans or to families with children enrolled 
in Connecticut’s Medicaid program called HUSKY A (Health insurance program for 
UninSured Kids and Youth), nor does it apply to families who choose to pay for ASD 
services out of pocket. Connecticut’s autism insurance statute speaks to a narrow pool 
of diagnosticians for the purposes of insurance reimbursement for services. For the 
purposes of these guidelines, we acknowledge that these are not the only clinicians who 
are competent to diagnose a child accurately. 
The 2009 autism insurance legislation was amended in 2013 as Public Act 13-
84. The amended legislation requires insurance companies to cover autism services for 
individuals who had previously been diagnosed with ASD under the DSM-IV criteria. In 
effect, those who met DSM-IV criteria for ASD but do not meet DSM-5 criteria must be 
provided autism services.
It is important to note that this statute is currently in effect as of the date of the 
printing of these guidelines. Providers and families should be aware of future changes in 
insurance legislation.
— 40 — Connecticut Guidelines for a Clinical Diagnosis of Autism Spectrum Disorder
DIAGNOSTIC ASSESSMENT
Assess core features of 
ASD
Table 7. Essential components of a diagnostic evaluation
Obtain and review 
medical and other 
available records
Conduct a family 
interview
HISTORY
MEDICAL RECORDS
	Routine well-child care and concerns raised over time
	Specialist evaluations by medical subspecialists
	Birth records, including newborn screening results
	Prior hospitalizations
	Medical tests and indications for those tests
	Medication history
	Prior treatments
PRIOR ASSESSMENTS
	Developmental evaluations or assessments
	Other evaluations or assessments
EDUCATIONAL RECORDS
	Birth to Three and educational evaluations
	Current school services and programs
	Data related to educational progress
FAMILY RECORDS
	Notes and videos
ESSENTIAL ELEMENTS:
	Reason for referral and referral source
	Family concerns
	Birth history, including pregnancy and neonatal 
course
	Developmental history, including when milestones 
were reached
	Child’s medical history
	Child’s early intervention and educational history
	Family history (medical, psychosocial) and three 
generation genetic history
	Assessment of family’s strengths and weaknesses
	Discussion of family’s goals
ASSESSMENT OF QUALITY AND 
CHARACTERISTICS OF SOCIAL
INTERACTION AND COMMUNICATION
	Deficits in social-emotional reciprocity
	Deficits in nonverbal communicative behaviors 
used for social interaction
	Deficits in developing, maintaining, and 
understanding relationships
Conduct a family 
interview
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DIAGNOSTIC ASSESSMENT (CONT.)
ASSESSMENT OF RESTRICTED, REPETITIVE AND 
STEREOTYPED PATTERNS OF BEHAVIOR SEEN 
IN CHILDREN WITH ASD
	Stereotyped or repetitive motor movements, use of 
objects or speech
	Insistence on sameness, inflexible adherences to 
routines, or ritualized patterns of verbal or nonverbal 
behavior
	Highly restricted, fixated interests that are abnormal 
in intensity or focus
	Hyper- or hyporeactivity to sensory input or unusual 
interest in sensory aspects of the environment
STANDARDIZED AUTISM-SPECIFIC 
DIAGNOSTIC INSTRUMENTS
	Formal parent interview instruments
 o Autism Diagnostic Interview-Revised (ADI-R)
	Formal behavioral observation instruments
 o Autism Diagnostic Observation Schedule, 2nd  
  Edition (ADOS-2)
 o Childhood Autism Rating Scale, 2nd Edition   
  (CARS2)
 o Social Responsiveness Scale-2 (SRS)
ADDITIONAL STANDARDIZED MEASURES 
PROVIDED IN APPENDIX D
COMPREHENSIVE MEDICAL EXAM 
	Height, weight and head circumference
	Dysmorphology examination
	Examination of the skin
	Assessment of motor development and coordination
	Hearing screening
	Vision screening or diagnostic
ASSESS CHILD FOR ANY ASSOCIATED 
MEDICAL CONDITIONS
	Seizure disorders
	Sleep disturbances
	Gastrointestinal disorders
	Feeding/eating disorders
Use autism-specific 
diagnostic instruments
Additional standardized 
measures when the 
diagnosis of ASD is 
undetermined
Comprehensive medical 
exam
Reprinted with permission from the American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th Edition.  
Washington, DC: American Psychiatric Publishing.
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DIAGNOSTIC ASSESSMENT (CONT.)
LABORATORY TESTS 
	Electroencephalography (EEG) when child has signs 
of seizures or language regression
	Phosphatase and tensin homolog (PTEN) gene 
testing when child’s head circumference is 2.5 times 
greater than age mean
	A methyl CpG-binding protein 2 (MECP2) for girls 
with regressive features of ASD
	Brain magnetic resonance imaging (MRI) for children 
with macrocephaly, microcephaly, seizures, or 
abnormal neurological exam
	Metabolic testing when child has cyclic vomiting or 
lethargy with minor illness
	Chromosomal microarray 
CONSIDER DIFFERENTIAL DIAGNOSES AND 
CO-OCCURRING CONDITIONS 
	Neurodevelopmental disorders
	Mental/behavioral disorders
	Medical conditions
	Genetic/Etiological factors
	Environmental factors
	Other conditions
CONSIDERATIONS FOR CHILDREN
	Very young children
	Older children, adolescents, and adults
	Child’s gender
	Child’s race and ethnicity
	Child’s language
CONSIDERATIONS FOR THE DIAGNOSTICIAN
	Didactic and continuous learning
	Exposure to standardized instruments
	Repeated opportunities to evaluate children with ASD
	Knowledge and skills
Differential diagnoses 
and co-occurring 
conditions
Additional considerations 
for the diagnostic 
evaluation
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Table 8. Differential disorders and co-occurring conditions 
CONDITION DIFFERENTIAL DIAGNOSIS
CO-
OCCURRING
CONDITIONS
Neurodevelopmental Disorders
 Attention-Deficit/Hyperactivity Disorder • •
 Intellectual Disability • •
 Language Disorder •
Social (Pragmatic) Communication 
Disorder •
 Stereotypic Movement Disorder • •
 Tourette’s disorder • •
Mental/Behavioral Disorders
 Anxiety disorders • •
 Conduct Disorder • •
 Depressive disorders • •
 Obsessive Compulsive Disorder • •
 Oppositional Defiant Disorder • •
 Personality disorders • •
 Reactive Attachment Disorder •
 Schizophrenia • •
 Selective Mutism •
Medical Conditions
 Epilepsy •
 Landau-Kleffner syndrome •
 Neonatal encephalopathy •
Genetic Conditions
 Angelman syndrome •
 Cornelia deLange syndrome •
 Down syndrome •
 Fragile X syndrome • •
 Lesch-Nyhan syndrome •
 Prader-Willi syndrome •
 Rett syndrome • •
 Smith-Lemli-Opitz syndrome •
 Tuberous sclerosis •
 Williams syndrome •
Environmental Factors
 Fetal alcohol spectrum disorder •
 Phenylketonuria (PKU) •
Other Conditions
 Blind or vision impairment •
 Deaf or hard of hearing • •
 Mitochondrial disorders • •
 Regulation disorders of sensory processing •
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Chapter 3 
Evaluation Results
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After completing a clinical diagnostic evaluation for ASD, the lead diagnostician and 
other members of the multidisciplinary team (as applicable), must review the information 
gathered and determine the appropriate diagnosis for the child. The results of the child’s 
clinical diagnostic evaluation are then shared with the family/caregiver(s). The team 
may discuss the results with the family after the final assessment is completed or shortly 
thereafter, provided there is minimum delay between the final assessment and the visit 
in which results are communicated. The diagnostician should explain to the family the 
entire process prior to beginning the evaluation so that expectations about the timeline for 
providing results are clear from the start. A more thorough written report is provided to the 
family when the oral results are shared or at a later date. 
Oral Feedback to the Family
There are a number of factors professionals must consider when sharing a diagnosis 
of ASD with families, the most important of which is tailoring the message to the needs of 
the individual child and family in a sensitive and respectful manner. Communicating results 
to the family should be a thoughtful process that includes planning on how to deliver the 
diagnosis, the use of supportive and nonjudgmental verbal and nonverbal language during 
the delivery, the review of the assessment results in understandable language, the delivery 
of the diagnosis, and the discussion of next steps. Ample time must be allowed for the 
diagnostician to be sure the family understands what is being communicated and for the 
parents to ask questions.
Meeting with the Family 
The diagnostic process from the time the family seeks information about their child 
through the delivery of the diagnosis is never as fast as a family wishes it to be. Professionals 
should consider that the family may have waited a considerable length of time to have 
their child evaluated and then diagnosed. It is critical that professionals are mindful of and 
empathetic to parents as they plan for the meeting, paying particular attention to parents who 
may have waiting a long time. Research suggests that the less time families have waited for 
a diagnosis, and the fewer professionals families have seen during the process, the more 
satisfied they are with the diagnostic process (Goin-Kochel, Mackintosh, & Myers, 2006).
Professionals should communicate diagnostic results to families in an environment 
that is private, where families can discuss the information and ask questions without 
interruptions or distractions. For Birth to Three providers and others who conduct 
assessments in the home, attention should be paid to ensuring the family members are 
physically comfortable and free from interruptions. In a clinic or other setting outside of the 
home, it is important to reduce any additional stressors. For example, the arrangement of the 
room can impact the interaction and alleviate some of the tensions (Nissenbaum, Tollefson, 
& Reese, 2002). If in a traditional conference room, the diagnostician and diagnostic team 
(as applicable), should not sit at the head or other side of the table than the family. Rather, 
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everyone should be seated comfortably as a team with equal investment in the success of the 
meeting and the child’s future.
It is generally recommended that young children are not in the room when the 
diagnostic results are discussed as they may understand some of what is communicated. 
However adolescents or adults may want to be involved in the discussion. If a family 
prefers their child to be present and the clinician prefers to meet with the parents privately, 
the diagnostician should express the importance of having an open dialogue without filters 
or constraints. For some families, feedback may need to be given over the course of two 
sessions, one with the parents and an additional session provided specifically for and with 
the child or teen. 
Meetings with families must be conducted in the families’ primary language and 
arrangements should be made in advance to have interpreters available, if needed. It is 
recommended that a neutral party and someone other than a family member serve as the 
interpreter. Under no circumstances should a sibling serve as an interpreter during a meeting 
with the family to discuss the results of a clinical diagnostic evaluation. Professional 
interpreter services are available by telephone and can be accessed for a fee.
It is critical for professionals to assess the family’s level of awareness and knowledge 
of ASD and to determine whether the family has considered the possibility of an ASD 
diagnosis in advance of the meeting. This should have been assessed at the onset of the 
evaluation process. Not all families that bring their child for an evaluation suspect that their 
child might have ASD or another type of developmental delay. For some families, receiving 
a diagnosis of ASD can be overwhelming, especially if they have only been exposed 
to negative media portrayals. Other families may feel a sense of relief in obtaining the 
diagnosis because their concerns and questions have been confirmed and identified, and as 
such, conversations about the diagnosis may be easiest with them (Nissenbaum et al., 2002).
Intentional use of verbal and non-verbal language. Professionals should be 
thoughtful in their choice of words when communicating a diagnosis to parents. The 
emphasis should focus on the child and his or her individuality, not the diagnostic label of 
ASD as concerns have been expressed that labeling a child with ASD defines the entirety of 
the child (Hodge, 2005). For example, people first language should be used in all references 
to the child (e.g., “child with ASD”, not “autistic child”). 
Certain words carry connotations that can mislead families and give the wrong 
impression. For example, it is preferable for professionals to use words such as “areas 
of challenge” and “difficulties” which will provide a more positive outlook of the 
child’s prognosis than “deficits” or “impairments”. When discussing observations of the 
child and/or the child’s future (prognosis), words such as “concerns” are preferred over 
those such as “worries,” because the term “worries” is perceived as ominous (Glascoe, 
2000). Diagnosticians should always use concrete terms (e.g., autism affects social and 
communication skills and behavior) to describe ASD to parents and families. Thus, 
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diagnosticians need to be intentional in their use of language while discussing an ASD 
diagnosis with parents and should use common language that is culturally relevant to the 
family. Parents should be reassured that ASD is not their fault, and that autism is not a result 
of poor parenting or anything else they may have done. 
The way words are delivered is as important as the words that are chosen; therefore non-
verbal communication skills are critical. Reflective listening is especially helpful in discussing 
diagnostic information because non-verbal communication can intentionally or unintentionally 
send positive or negative cues. Positive cues show empathy and compassion which can help parents 
receive the diagnosis and include relaxed body language, leaning in toward the family, nodding 
appropriately and showing a genuine interest in the child and the family. Negative cues such as 
typing in an electronic medical record, responding to text messages, taking phone calls, looking 
frequently at a watch or clock, holding a rigid posture, eating and permitting numerous interruptions 
are all hindrances to the diagnostic conversation and should be avoided. Negative cues convey 
a lack of interest, even if it is not the intention. Families deserve the undivided attention of the 
diagnostician and other team members when discussing results.
Communicating the Diagnosis 
When delivering the results of the clinical diagnostic evaluation to families, 
diagnosticians should be clear and state a diagnosis of ASD using direct and understandable 
language. Even if it is hard to hear at the time, “sugarcoating” or glossing over a diagnosis 
may not be helpful to families. In doing this, diagnosticians should pace the meeting with 
the family, to be sure that the family is assimilating the information being discussed. 
They should offer to rephrase or repeat information to ensure the family understands 
the evaluations and conclusions. If a family decides that they need time before taking in 
more information, diagnosticians should accommodate the needs of the family by making 
arrangements to reconvene the meeting within a relatively short period of time. It is 
important that diagnosticians verbally acknowledge the family’s emotions and respond to 
the family’s verbal and non-verbal cues without judgment, showing both professionalism 
and empathy. It should never be assumed that families will be either overly emotional or 
completely unemotional when the diagnosis is given; different people handle important 
life-changing news in different ways (e.g., grief, anger, shock, frustration). Diagnosticians 
should not over personalize reactions families may have, but be reflective and work toward 
maintaining a therapeutic relationship with families.
Some parents may view diagnosticians as powerful people and believe that a 
diagnosis will change their child’s identity and determine what his/her future development 
will be (Hodge, 2005). Given that the prognosis for each child with ASD is dependent on a 
variety of factors, it is important for the diagnostician to be clear about what is known and 
what is not known about the child’s future. 
Parents report that it is critical for diagnosticians to express hope when a diagnosis 
of ASD is given as it can activate parents to seek care for their children (Nissenbaum et al., 
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2002). Hope can be provided to parents by discussing the child’s strengths and a range of 
effective interventions that can help the child reach his/her optimum level of independence. 
At the same time, it is also important for diagnosticians to refrain from imposing feelings of 
any kind on families. 
There is great variability in the information needs of the family after the diagnosis 
is given. It is important for diagnosticians to assess what families are ready to hear when 
communicating results (Osbourne & Reed, 2008). Some families may prefer to receive 
information in phases. Other families may want a detailed prognosis for the child. They also 
may want all of the information possible at the time of diagnosis, rather than processing 
pieces. This can lead to information overload which may overwhelm families, but some 
families express that they would rather have the information available as it may be needed 
in the future. It is recommended that when providing families with the written report, it is 
important to remind them that it includes the same information being shared (e.g., about the 
diagnosis, recommendations, local resources, family support groups, and how to contact 
Connecticut Child Development Infoline for further resources).
While some families think that diagnosticians are too negative in delivering and 
discussing a diagnosis, diagnosticians at times feel that families are too positive when 
discussing future outcomes for their child, so it is important to find an appropriate balance 
during the discussion (Nissenbaum et al., 2002). The long term future implications 
(e.g., about independent living, employment) are not appropriate unless the child is of 
transition age or older (e.g., age 13 and older). Key in the message to families should be an 
acknowledgement of the child’s and family’s strengths, while also recognizing the challenges 
of parenting a child with ASD. It is appropriate to ask a family at this point how they are 
coping with their challenges.
Clear explanation of the diagnostic criteria. The publication of the DSM-5 (APA, 
2013) might present challenges and confusion for families concerning their child’s diagnosis 
and a potential change in diagnostic classification. It is essential that the diagnostician provide 
families with a clear explanation of what criteria they used to arrive at an ASD diagnosis. 
Families might have increased anxiety, especially families of children who currently have a 
DSM-IV (APA, 1994) diagnosis of autism who are worried their child might ‘lose’ the diagnosis. 
Diagnosticians should expect that families will have questions about what ASD is, how autism 
is different now than it was before, and if their child will be entitled to different services and 
supports. In these cases, the diagnostician should reassure families that their child will not lose 
their diagnosis and that the DSM-5 contains specific language to protect this. Diagnosticians 
might also refer families to appropriate community supports, advocacy organizations, or online 
information that helps explain the changes that have been made.
Discussing Next Steps
After talking with families about the diagnosis of ASD, diagnosticians should provide 
them with recommendations that can guide their next steps. For children under the age of 
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three, a referral to the early intervention system, Birth to Three, can be made by contacting 
Child Development Infoline (1-800-505-7000, also see Appendix F). For children who 
are age three or older, a referral for an evaluation by the local school district planning and 
placement team (PPT) to determine a child’s need for special education services should be 
provided. If a school-age child is already receiving special education services, the parent 
may wish to request a PPT meeting to consider the information obtained from the clinical 
evaluation, and, if necessary, to request that the district conduct its own evaluation. Two 
important resources families may find helpful are the Connecticut State Department of 
Education’s Guidelines for Identification and Education of Children and Youth with Autism 
Spectrum Disorders (2005) and the Connecticut Birth to Three System’s Autism Spectrum 
Disorders: Intervention Guidance for Parents (2011). In addition, parents should be referred 
to the Connecticut Medical Home Initiative which provides care coordination for children 
and youth with special health care needs age newborn through 21 (see Appendix F for 
details). Finally, the diagnostician should discuss referrals and future visits to follow up on 
referrals (e.g., visits to specialists).
The Written Evaluation Report
The report should be written in a manner that fosters collaboration among 
diagnosticians and parents and ensures optimal outcomes for the child. A thorough and clear 
written report is critical and should be provided to the child’s family within a reasonable 
timeframe following the evaluation.
Components of the Report
The report must contain an objective but sensitive discussion of how the core features 
of ASD are exhibited (or not) by the child. This is essential, even if the diagnosis is based 
solely on clinical judgment. The written report serves as a means of documenting clinical 
findings to the family and other diagnosticians (e.g., teachers, school administrators, special 
educators). The report may also be needed in order to access services for the child. The 
report’s recommendations should serve to unify everyone involved with the child and family 
and should guide treatment as well as inform other providers such as early intervention and 
special education professionals.
The report should begin with a statement about the reason for the referral and any 
pertinent background information, including a developmental and family history. Next, 
a discussion of any testing performed previous to the evaluation, as well as the results 
of the review of the child’s prior medical, educational, intervention and other records is 
described. The clinical portion of the report must include a description of the diagnostic 
process, including any instruments administered and the procedures and personnel involved 
in conducting the diagnostic evaluation with a clear description of which diagnostic criteria 
were used to arrive at the diagnosis. The number of times that the child was seen and the 
overall length of the evaluation should be included. Also vital to include in the clinical 
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section of the report are the data from the family interview and direct observations of the 
child to support the diagnosis of ASD. A description of how the child’s presenting symptoms, 
behavior and history meet the current criteria for a diagnosis of ASD should be documented. 
The report should contain a section describing referrals for services, recommendations for 
interventions and for further assessment(s), if necessary, resources for parents, and a follow-
up plan. The child’s strengths should be prominently detailed throughout.
Observations and concrete recommendations for resources that can lead a 
family to services. A diagnostic evaluation is different from an assessment for intervention. 
The report resulting from the diagnostic evaluation should be individualized to the 
specific child and should refer to the assessments that were performed. For example, if 
a diagnostician finds that the child has a particular motivator (e.g., bubbles), that should 
be included in the report. It is helpful if the diagnostician provides a description of the 
challenges that need to be addressed (e.g., motor planning, following directions, initiating 
conversation) to assist those who will plan intervention services for the child and family. 
A report resulting from a diagnostic evaluation should not prescribe the service providers 
by name, or number of hours of services a child needs to meet educational and behavioral 
outcomes. Rather, the report should provide individualized recommendations that come from 
what the diagnostician has learned about the child from the evaluation. 
The recommendations that diagnosticians give to parents are likely to be distributed 
in multiple venues (e.g. early intervention programs, special education programs, medical 
providers). It is then up to those who are responsible to plan and deliver intervention services 
to the child to apply the recommendations The recommendations should be detailed, address 
all areas of a child’s daily life and include all developmental domains (e.g., academic, social, 
behavioral). Recommendations may include for example, “the child will need to have a 
communication system as soon as possible to learn to express wants and needs to others,” 
or “the child would benefit from programs that improve social skills and opportunities with 
non-disabled peers.” The report should conclude with any referrals or consultations the 
child and family need. Sources of support and information for parents (e.g., parent advocacy 
groups as well as information and support groups) should be provided. 
Sharing Diagnostic Information
During the oral discussion with families, diagnosticians should emphasize the 
importance of communication and collaboration across those who are and will be helping 
the child and family. The diagnostician should explain to the family what a signed consent 
for the release of the written report means, and how they can choose to share the report 
with others. In particular, sharing the report with the child’s pediatrician or medical home 
should be encouraged. It is also important to emphasize to families that sharing the report 
will assist with communication and collaboration among the different service agencies 
and providers as they help their child and them. Families must also know that the report is 
theirs to share or not share.
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Chapter 4 
The Use of the Evaluation 
for Early Intervention 
and Special 
Education
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There are important distinctions between a clinical diagnosis of ASD and a 
determination of eligibility for special education because of ASD. Children with a clinical 
diagnosis of ASD do not automatically receive special education, nor do students who are 
eligible for special education under the Individuals with Disabilities Education Improvement 
Act of 2004 (IDEA) within the category of autism have to have a clinical diagnosis of 
ASD. The clinical diagnosis refers to the diagnostic process of identifying how specific 
symptoms and behaviors are exhibited by a person and the subsequent clinical diagnosis of 
ASD by a physician, psychologist, or other qualified health or mental health professional. An 
evaluation determining a student’s eligibility for special education is conducted by a team 
of diagnosticians, including parents, and is conducted strictly for the purpose of identifying 
whether a child is eligible to receive special education and related services. An evaluation 
assessing eligibility for special education does not replace a clinical diagnosis of ASD, nor 
does a clinical diagnosis of ASD determine eligibility for special education. The IDEA and its 
related regulations are the legal and regulatory bases for early intervention, called Part C, as 
well as special education in public schools, called Part B. 
Eligibility Determination for Children  
Ages Birth to Three
Part C of IDEA is the federal program administered by states to provide early 
intervention services for eligible infants and toddlers. The Birth to Three System 
in Connecticut serves young children newborn up until age three and is currently 
administered by the CT State Department of Developmental Services (DDS). In 
Connecticut, all children referred to the Birth to Three System who are 16 months of age 
or older are screened for ASD. For those with a positive screening, an autism assessment 
is provided at no cost to the family either through the program that conducted the initial 
evaluation or by one of the autism-specific early intervention programs. The assessment 
will determine whether the child receives a diagnosis of ASD. In order for diagnostic 
assessments performed by diagnosticians outside of the Birth to Three programs to be 
accepted by Birth to Three, the diagnostician must be a licensed physician, clinical 
psychologist or clinical social worker and the assessment must meet the minimum 
standards of this guideline. Children under age three with a DSM-5 diagnosis of ASD are 
automatically eligible for early intervention services and, at the discretion of the parent, 
may enroll in an autism-specific or general early intervention program. A child may 
receive the diagnosis either prior to or after the referral to Birth to Three. 
Services for children with ASD in the Birth to Three System are delivered 
in accordance with Service Guideline #1: Autism Spectrum Disorder, Intervention 
Guidance for Service Providers (2011). A version especially for parents, is called Service 
Guideline #1: Autism Spectrum Disorder, Intervention Guidance for Parents (2011). Both 
publications are available on the Birth to Three website (www.birth23.org) or from any 
Birth to Three program.
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Eligibility Determination for Children Ages Three 
Through Twenty-One
Part B of IDEA defines children with disabilities as those children, ages 3–21, who 
have been evaluated by the school personnel and demonstrate developmental, functional, 
academic and/or behavioral needs that have an impact on the child’s ability to access and 
participate in their general education and requires special education. In CT, planning and 
placement teams (PPTs) determine eligibility for special education.  PPTs consist of the 
child’s parents and professionals representing teaching, administrative and related service 
staff, as necessary. PPTs review referrals to special education, assess whether a child needs 
to be evaluated, determine what evaluations will be administered, decide whether a child is 
eligible for special education, and plan an appropriate individualized educational program 
(IEP) for the student (Connecticut State Department of Education, 2007). 
During the course of the evaluation to determine eligibility for special education, 
educators and related service personnel draw upon information from a variety of sources, 
including parental report/answers to questionnaires, and ensure that information is 
documented and carefully considered. If the child is found eligible for special education, 
the evaluation information must be sufficient to guide the development of an IEP. The 
IEP addresses the unique needs of the child within the school environment, which may 
be similar to or different from the needs of the child in other environments. The IEP is 
developed, reviewed, and revised collaboratively by the PPT at least once annually. 
Autism Defined Under IDEA
A child who is found eligible for special education is classified into one of 13 disability 
categories, including autism. According to IDEA, autism is defined as:
(1)(i) Autism means a developmental disability significantly affecting verbal and nonverbal 
communication and social interaction, generally evident before age three, that adversely 
affects a child’s educational performance. Other characteristics often associated with 
autism are engagement in repetitive activities and stereotyped movements, resistance 
to environmental change or change in daily routines, and unusual responses to sensory 
experiences. (ii) Autism does not apply if a child’s educational performance is adversely 
affected primarily because the child has an emotional disturbance, as defined in paragraph 
(c)(4) of this section. (iii) A child who manifests the characteristics of autism after age three 
could be identified as having autism if the criteria in paragraph (c)(1)(i) of this section are 
satisfied. (Individuals with Disabilities Act of 2004, 34 CFR §300.8 (1)(i)-(iii))
The CT State Department of Education describes the possible impact of ASD on 
components of the educational process as follows: “Since the central deficits in ASD (i.e., 
social reciprocity and interaction, communication, and repetitive behaviors) affect components 
that are key to the educational process, ASD may adversely impact a child‘s performance 
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in one, several, or all of the following areas: academics, social/emotional growth, life-skills 
acquisition, communication, and the ability to use and maintain skills across a range of 
applications and settings” (Connecticut State Department of Education, 2005, page 15).
IDEA mandates that consideration be given to the results of evaluations from outside 
providers, but PPTs are not required to adopt the recommendations from independent 
evaluators or use their evaluation information in determining a child’s eligibility 
for special education and/or in the development of a student’s educational program. 
Sometimes this statement is misinterpreted to mean that educators do not have to accept 
the diagnosis of ASD or other conditions. It is not the role of educators to challenge a 
clinical diagnosis. The decision about a child’s eligibility for special education is based 
upon a comprehensive evaluation of the child to determine if: 1) the child is a child with a 
disability; and 2) whether the child requires special education. 
Developmental Delay
In some instances, a young child will have a clinical diagnosis of ASD and 
subsequently will be evaluated by the school district PPT. The PPT may determine that the 
child is eligible for special education because of developmental delay rather than ASD. It is 
critical to understand that just because a child falls under developmental delay for special 
education eligibility does not negate the child’s clinical diagnosis of ASD. The disability 
category of developmental delay may apply to children from age three to six years. By their 
sixth birthday, children who continue to require special education services must be re-evaluated 
to determine if a disability that requires special education continues to exist and to identify a 
disability category other than developmental delay. 
Summary
This section distinguished between two separate processes: the process of obtaining 
a clinical diagnosis of ASD and the process of determining eligibility for early intervention 
services and for special education. The challenge is to achieve an optimal level of collaboration 
and communication between the family and the educational, medical and other diagnosticians 
and agencies involved in the clinical diagnosis and in the determination of eligibility for special 
education services. Parents are central in this process and are encouraged to collaborate with 
the medical and educational diagnosticians involved with their child by sharing results from 
clinical diagnosticians with schools and to share school evaluations with their child’s clinicians. 
Any parents with children eligible for special education because of autism are advised, if their 
children do not have a clinical diagnosis of ASD, to share the educational evaluation with the 
child’s pediatrician who should refer the child for a clinical evaluation which may be covered 
by insurance (see text box 1, page 39). School district personnel are separate from the clinical 
diagnostic process, they are not clinical personnel, and as members of the PPT are qualified 
to address educational interventions. Pediatricians and other clinical providers may have 
other recommendations that the school district may or may not address. 
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DSM-5 Definition of Autism Spectrum Disorder
 
299.00 Autism Spectrum Disorder
A. Persistent deficits in social communication and social interaction across multiple contexts, 
as manifested by the following, currently or by history (examples are illustrative, not 
exhaustive; see text):
1. Deficits in social-emotional reciprocity, ranging, for example, from abnormal social 
approach and failure of normal back-and-forth conversation; to reduced sharing of 
interest, emotions, or affect; to failure to initiate or respond to social interactions.  
2. Deficits in nonverbal communicative behaviors used to social interaction, ranging, 
for example, from poorly integrated verbal and nonverbal communication; to 
abnormalities in eye contact and body language or deficits in understanding and use 
of gestures; to a total lack of facial expressions and nonverbal communication.  
3. Deficits in developing, maintaining, and understanding relationships, ranging, for 
example, from difficulties adjusting behavior to suit various social contexts, to 
difficulties in sharing imaginative play or in making friends; to absence of interest 
in peers.  
Specify current severity:
Severity is based on social communication impairments and restricted, repetitive 
patterns of behavior (see Table A1)
B. Restricted, repetitive patterns of behavior, interests, or activities, as manifested by at least 
two of the following, currently or by history (examples are illustrative, not exhaustive; see 
text): 
1. Stereotyped or repetitive motor movements, use of objects, or speech (e.g., simple 
motor stereotypies, lining up toys or flipping objects, echolalia, idiosyncratic 
phrases)
2. Insistence on sameness, inflexible adherence to routines, or ritualized patterns of 
verbal or nonverbal behavior (e.g., extreme distress at small changes, difficulties 
with transitions, rigid thinking patterns, greeting rituals, need to take same route or 
eat same food every day).
3. Highly restricted, fixated interests that are abnormal in intensity or focus 
(e.g., strong attachment to or preoccupation with unusual objects, excessively 
circumscribed or perseverative interests). 
4. Hyper- or hyporeactivity to sensory input or unusual interest in sensory aspects of 
the environment (e.g., apparent indifference to pain/temperature, adverse response 
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to specific sounds or textures, excessive smelling or touching of objects, visual 
fascination with lights or movement).  
Specify current severity:
Severity is based on social communication impairments and restricted, repetitive 
patterns of behavior (see Table A1)
C. Symptoms must be present in the early developmental period (but may not become fully 
manifested until social demands exceed limited capacities, or may be masked by learned 
strategies in later life).
D. Symptoms cause clinically significant impairment in social, occupational, or other 
important areas of current functioning.  
E. These disturbances are not better explained by intellectual disability (intellectual 
developmental disorder) or global developmental delay.  Intellectual disability and autism 
spectrum disorder frequently co-occur; to make comorbid diagnoses of autism spectrum 
disorder and intellectual disability, social communication should be below that expected of 
general developmental level. 
Note: Individuals with a well-established DSM-IV diagnosis of autistic disorder, 
Asperger’s disorder, or pervasive developmental disorder not otherwise specified should 
be given the diagnosis of autism spectrum disorder.  Individuals who have marked deficits 
in social communication, but whose symptoms do not otherwise need criteria for autism 
spectrum disorder, should be evaluated for social (pragmatic) communication disorder.  
Specify if:  
 With or without accompanying intellectual impairment
 With or without accompanying language impairment
Associated with a known medical or genetic condition or environmental factor 
(Coding note:  Use additional code to identify the associated medical or genetic 
condition.)
Associated with another neurological, mental, or behavioral disorder (Coding 
note:  Use additional code[s] to identify the associated neurodevelopmental, mental, or 
behavioral disorder[s].)
With catatonia (refer to the criteria for catatonia associated with another mental 
disorder, pp. 119-120, for definition) (Coding note: Use additional cost 293.89 [F06.1] 
catatonia associated with autism spectrum disorder to indicate the presence of the 
comorbid catatonia).  
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Table B1. Severity levels for DSM-5 definition of autism spectrum disorder
Severity Level Social communication Restricted, repetitive 
behaviors
Level 3
“Requiring very 
substantial support”
Severe deficits in verbal and nonverbal 
social communication skills cause severe 
impairments in functioning, very limited 
initiation of social interactions, and 
minimal response to social overtures 
from others. For example, a person with 
few words of intelligible speech who 
rarely initiates interaction and, when he 
or she does, makes unusual approaches 
to meet needs only and responds to only 
very direct social approaches.  
Inflexibility of behavior, 
extreme difficulty coping 
with change, or other 
restricted/
repetitive behaviors 
markedly interfere with 
functioning in all spheres. 
Great distress/
difficulty changing focus or 
action.
Level 2
“Requiring 
substantial support”
Marked deficits in verbal and nonverbal 
social communication skills; social 
impairments apparent even with 
supports in place; limited initiation 
of social interactions; and reduced or 
abnormal responses to social overtures 
from others. For example, a person 
who speaks simple sentences, whose 
interaction is limited to narrow special 
interests, and who has markedly odd 
nonverbal communication.  
Inflexibility of behavior, 
difficulty coping with 
change, or other restricted/
repetitive behaviors appear 
frequently enough to be 
obvious to the casual 
observer and interfere with 
functioning in a variety of 
contexts. Distress and/or 
difficulty changing focus or 
action.  
Level 1
“Requiring 
support”
Without supports in place, deficits in 
social communication cause noticeable 
impairments. Difficulty initiating social 
interactions, and clear examples of 
atypical or unsuccessful responses to 
social overtures of others. May appear 
to have decreased interest in social 
interactions. For example, a person who 
is able to speak in full sentences and 
engages in communication but whose 
to-and-fro conversation with others fails, 
and whose attempts to make friends are 
odd and typically unsuccessful.  
Inflexibility of behavior 
causes significant 
interference with functioning 
in one or more contexts. 
Difficulty switching between 
activities. Problems of 
organization and planning 
hamper independence.  
Reprinted with permission from the Diagnostic and Statistical Manual of Mental Disorders, 
Fifth Edition, (Copyright 2013). American Psychiatric Association.
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DSM-IV-TR Crosswalk DSM-5
(1) Social (1a-1d)
(2) Communication (2a-2b)
A. Social communication and social 
interaction
1 (a) marked impairment in the use of multiple 
nonverbal behaviors such as eye-to-eye gaze, facial 
expression, body postures, and gestures to regulate 
social interaction
 1(a)                       A1 A1. Deficits in social-emotional reciprocity, ranging, 
for example, from abnormal social approach and 
failure of normal back-and-forth conversation; to 
reduced sharing of interests, emotions, or affect; to 
failure to initiate or respond to social interactions.
1 (b) failure to develop peer relationships 
appropriate to developmental level
 1(b)
1 (c) a lack of spontaneous seeking to share 
enjoyment, interests, or achievements with other 
people (e.g., by a lack of showing, bringing, or 
pointing out objects of interest)
  1(c)                  A2 A2. Deficits in nonverbal communicative behaviors 
used for social interaction, ranging, for example, 
from poorly integrated verbal and nonverbal 
communication; to abnormalities in eye contact and 
body language or deficits in understanding and use 
of gestures; to a total lack of facial expressions and 
nonverbal communication.
1 (d) lack of social or emotional reciprocity  1(d)
2 (a) delay in, or total lack of, the development 
of spoken language (not accompanied by an 
attempt to compensate through alternative modes of 
communication such as gesture or mime)
 2(a) 
2 (b) in individuals with adequate speech, marked 
impairment in the ability to initiate or sustain a 
conversation with others
 2(b)                   A3 A3. Deficits in developing, maintaining, and 
understanding relationships, ranging, for example, 
from difficulties adjusting behavior to suit various 
social contexts; to difficulties in sharing imaginative 
play or in making friends; to absence of interest in 
peers.
2 (c) stereotyped and repetitive use of language or 
idiosyncratic language
 2(c)
2 (d) lack of varied, spontaneous make-believe 
play or social imitative play appropriate to 
developmental level
 2(d)
3. Restricted, repetitive behavior B. Restricted, repetitive behavior
3 (a) encompassing preoccupation with one or 
more stereotyped and restricted patterns of interest 
that is abnormal either in intensity or focus
 3(a)                   B1 B1. Stereotyped or repetitive motor movements, 
use of objects, or speech (e.g., simple motor 
stereotypies, lining up toys or flipping objects, 
echolalia, idiosyncratic phrases).
3 (b) apparently inflexible adherence to specific, 
nonfunctional routines or rituals
 3(b)                   B2 B2. Insistence on sameness, inflexible adherence to 
routines, or ritualized patterns of verbal or nonverbal 
behavior (e.g., extreme distress at small changes, 
difficulties with transitions, rigid thinking patterns, 
greeting rituals, need to take same route or eat same 
food every day).
3 (c) stereotyped and repetitive motor mannerisms 
(e.g., hand or finger flapping or twisting, or 
complex whole body movements 
 3(c)                   B3 B3. Highly restricted, fixated interests that are 
abnormal in intensity or focus (e.g., strong 
attachment to or preoccupation with unusual objects, 
excessively circumscribed or perseverative interests).
3 (d) persistent preoccupation with parts of objects  3(d)           (new)B4 B4. Hyper- or hyporeactivity to sensory input 
or unusual interest in sensory aspects of the 
environment (e.g., apparent indifference to pain/
temperature, adverse response to specific sounds or 
textures, excessive smelling or touching of objects, 
visual fascination with lights or movement).
Figure B1. Crosswalk of diagnostic criteria for DSM-IV-TR Autistic Disorder and  
DSM-5 Autism Spectrum Disorder
Reprinted with permission from the American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th Edition. Washington, DC: American Psychiatric Publishing.
Reprinted with permission from the American Psychiatric Association. (2000). Diagnostic and Statistical Manual of Mental Disorders, IV-TR. Washington, DC: American Psychiatric Publishing.
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DSM-IV-TR Definition of Autistic Disorder, Asperger syndrome and Pervasive 
Developmental Delay-Not Otherwise Specified
299.00 Autistic Disorder
A. A total of six (or more) items from (1), (2), and (3), with at least two from (1), and one each 
from (2) and (3):
(1) qualitative impairment in social interaction, as manifested by at least two of the  
 following: 
(a) marked impairment in the use of multiple nonverbal behaviors such as eye-
to-eye gaze, facial expression, body postures, and gestures to regulate social 
interaction 
(b) failure to develop peer relationships appropriate to developmental level 
(c) a lack of spontaneous seeking to share enjoyment, interests, or achievements 
with other people (e.g., by a lack of showing, bringing, or pointing out objects 
of interest) 
(d) lack of social or emotional reciprocity 
(2)  qualitative impairments in communication as manifested by at least one of the  
 following:
(a) delay in, or total lack of, the development of spoken language (not 
accompanied by an attempt to compensate through alternative modes of 
communication such as gesture or mime) 
(b) in individuals with adequate speech, marked impairment in the ability to 
initiate or sustain a conversation with others 
(c) stereotyped and repetitive use of language or idiosyncratic language 
(d) lack of varied, spontaneous make-believe play or social imitative play 
appropriate to developmental level 
(3)  restricted repetitive and stereotyped patterns of behavior, interests, and activities, as  
 manifested by at least one of the following: 
(a) encompassing preoccupation with one or more stereotyped and restricted 
patterns of interest that is abnormal either in intensity or focus 
(b) apparently inflexible adherence to specific, nonfunctional routines or rituals 
(c) stereotyped and repetitive motor mannerisms (e.g., hand or finger flapping or 
twisting, or complex whole-body movements)
(d) persistent preoccupation with parts of objects. 
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B. Delays or abnormal functioning in at least one of the following areas, with onset prior to 
age 3 years: (1) social interaction, (2) language as used in social communication, or (3) 
symbolic or imaginative play. 
C. The disturbance is not better accounted for by Rett’s Disorder or Childhood Disintegrative 
Disorder.
299.80 Asperger’s Disorder
A. Qualitative impairment in social interaction, as manifested by at least two of the following: 
(1)   marked impairment in the use of multiple nonverbal behaviors such as eye-to-eye gaze, 
 facial expression, body postures, and gestures to regulate social interaction 
(2) failure to develop peer relationships appropriate to developmental level 
(3) a lack of spontaneous seeking to share enjoyment, interests, or achievements with  
 other people (e.g., by a lack of showing, bringing, or pointing out objects of interest  
 to other people) 
(4) lack of social or emotional reciprocity. 
B. Restricted repetitive and stereotyped patterns of behavior, interests, and activities, as 
manifested by at least one of the following: 
(1) encompassing preoccupation with one or more stereotyped and restricted patterns of  
 interest that is abnormal either in intensity or focus 
(2) apparently inflexible adherence to specific, nonfunctional routines or rituals 
(3) stereotyped and repetitive motor mannerisms (e.g., hand or finger flapping or twisting,  
 or complex whole-body movements)
(4) persistent preoccupation with parts of objects. 
C. The disturbance causes clinically significant impairment in social, occupational, or other 
important areas of functioning. 
D. There is no clinically significant general delay in language (e.g., single words used by age 2 
years, communicative phrases used by age 3 years).
E. There is no clinically significant delay in cognitive development or in the development of 
age-appropriate self-help skills, adaptive behavior (other than in social interaction), and 
curiosity about the environment in childhood. 
F. Criteria are not met for another specific Pervasive Developmental Disorder or 
Schizophrenia.
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299.80 Pervasive Developmental Disorder Not Otherwise Specified (Including Atypical 
Autism)
This category should be used when there is a severe and pervasive impairment in the 
development of reciprocal social interaction associated with impairment in either verbal 
or nonverbal communication skills or with the presence of stereotyped behavior, interests, 
and activities, but the criteria are not met for a specific Pervasive Developmental Disorder, 
Schizophrenia, Schizotypal Personality Disorder, or Avoidant Personality Disorder. For 
example, this category includes “atypical autism”—presentations that do not meet the criteria 
for Autistic Disorder because of late age at onset, atypical symptomatology, or subthreshold 
symptomatology, or all of these.
Reprinted from: American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, 
Fourth Edition, Text Revision (DMS-IV-TR). Washington, DC: American Psychiatric Publishing, 2000.
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ICD-10 Criteria for Childhood Autism (F84.0)
A. Abnormal or impaired development is evident before the age of 3 years in at least one out of the 
following areas:
 (1) receptive or expressive language as used in social communication;
 (2) the development of selective social attachments or of reciprocal social interaction;
 (3) functional or symbolic play.
B. A total of at least six symptoms from (1), (2), and (3) must be present, with at least two from (1) and 
at least one from each of (2) and (3):
(1) Qualitative abnormalities in reciprocal social interaction are manifest in at least two of the 
following areas:
  (a) failure adequately to use eye-to-eye gaze, facial expression, body    
  posture and gesture to regulate social interaction;
  (b) failure to develop (in a manner appropriate to mental age, and despite   
  ample opportunities) peer relationships that involve a mutual sharing of    
  interests, activities and emotions;
  (c) A lack of socio-emotional reciprocity as shown by an impaired or    
  deviant response to other people’s emotions; or lack of modulation of    
  behaviour according to social context, or a weak integration of social,    
  emotional and communicative behaviours;
  (d) lack of spontaneous seeking to share enjoyment, interests, or     
  achievements with other people (e.g., a lack of showing, bringing, or    
  pointing out to other people objects of interest to the individual).
 (2) Qualitative abnormalities in communication are manifest in at least one of the  
following areas:
(a) a delay in, or total lack of, development of spoken language that is not accompanied 
by an attempt to compensate through the use of gesture or mime as alternative modes of 
communication (often preceded by a lack of communicative babbling);
  (b) relative failure to initiate or sustain conversational interchange (at    
  whatever level of language skills are present) in which there is reciprocal   
  to and from responsiveness to the communications of the other person;
  (c) stereotyped and repetitive use of language or idiosyncratic use of    
  words or phrases;
  (d) lack of varied spontaneous make-believe or (when young) social    
  imitative play.
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(3) Restricted, repetitive, and stereotyped patterns of behaviour, interests and activities are 
manifest in at least one of the following areas:
(a) an encompassing preoccupation with one or more stereotyped and restricted patterns 
of interest that are abnormal in content or focus; or one or more interests that are 
abnormal in their intensity and circumscribed nature although not abnormal in their 
content or focus;
  (b) apparently compulsive adherence to specific, non-functional, routines or rituals;
 (c) stereotyped and repetitive motor mannerisms that involve either hand  or finger 
flapping or twisting, or complex whole body movements;
(d) preoccupations with part-objects or non-functional elements of play materials (such 
as their odour, the feel of their surface, or the noise or vibration that they generate);
C. The clinical picture is not attributable to the other varieties of pervasive developmental disorder; 
specific developmental disorder of receptive language (F82.0) with secondary socio-emotional 
problems; reactive attachment disorder (F94.1) or disinhibited attachment disorder (F94.2); mental 
retardation (F70- F72) with some associated emotional or behavioural disorder; schizophrenia (F20.-) 
of unusually early onset; and Rett’s syndrome (F82.4).
Source: International Classification of Diseases: Diagnostic Criteria for Research, tenth edition, by the World Health 
Organization, 1992, Geneva Switzerland: Author. Reprinted with permission
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Table D1. Additional standardized measures 
Instrument
(Reference)
Description Method of 
Administration
Age 
Range 
Administered 
by
Administration 
Time
Developmental assessments
Battelle De-
velopmental 
Inventory, 2nd 
Edition
(Newborg, 
2004)
Measures person-
al-social, adap-
tive, motor, com-
munication, and 
cognitive ability 
Formal child 
interaction
Birth to 7 
years 11 
months
Teachers, in-
cluding infant, 
preschool, 
primary, and 
special educa-
tion teachers
Assessment: 
60-90 minutes 
Screening test:  
10-30 minutes
Bayley Scales 
of Infant and 
Toddler Devel-
opment–III
(Bayley, 
2006)
Measures develop-
ment across five 
scales: cognitive, 
motor, language, 
social-emotional, 
adaptive behav-
ior. 
Formal child 
interaction and 
parent report 
via question-
naire
One 
to 42 
months
Highly trained 
person. 
Trained staff 
without gradu-
ate or profes-
sional training 
in assessment 
may adminis-
ter and score 
the assessment 
under supervi-
sion.
30 to 90  
minutes
Brigance 
Inventory of 
Early Devel-
opment-II
(Brigance, 
2004)
Measures physi-
cal and language 
development, aca-
demic/cognitive 
functioning, daily 
living skills, fine 
and gross motor 
skills, receptive 
and expressive 
communication, 
social and emo-
tional skills and 
adaptive behav-
ior.
Child  
interaction/ 
observation 
and parent  
interview
Birth 
through 
seven 
years
Teacher, 
school psy-
chologist or 
developmental 
expert, or 
other early 
education  
professional.
20 to 55 
 minutes
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Instrument
(Reference)
Description Method of 
Administration
Age 
Range 
Administered 
by
Administration 
Time
Leiter Interna-
tional Perfor-
mance Scale, 
Revised
(Roid & Mill-
er, 1998)
Measures intel-
ligence among 
children who are 
non-verbal, non 
English speak-
ing, cognitively 
impaired, or hear-
ing or speech im-
paired. Measures 
include reasoning, 
visualization, 
memory, and at-
tention. 
Individually 
administered 
game-like tasks
Ages two 
to 21 
years
Professional 
who has re-
ceived super-
vised training 
and practice. 
It should be 
interpreted 
by someone 
with gradu-
ate training in 
psychological 
assessment.
40 to 90  
minutes 
Mullen Scales 
of Early 
Learning
(Mullen, 
1995)
Measures motor 
and cognitive 
abilities across 
five scales: gross 
motor, visual 
reception, fine 
motor, expressive 
language, and re-
ceptive language. 
Formal child 
interaction
Birth 
to 68 
months
A professional 
with training 
or practical ex-
perience in the 
clinical assess-
ment of infants 
and young 
children.  
15 to 60 min-
utes, depending 
on the age of 
the child.
Stanford-Binet 
Intelligence 
Scales, 5th 
edition
(Roid, 2003)
Measures four 
areas of cogni-
tive ability: verbal 
reasoning; quan-
titative reasoning; 
abstract/visual 
reasoning; and 
short-term mem-
ory. 
Formal child 
interaction
2 to 23 
years
The test is ad-
ministered by 
trained diag-
nosticians
30 to 90  
minutes
Wechsler Pre-
school and Pri-
mary Scales of 
Intelligence, III
(Wechsler, 
2002)
Measures full scale 
IQ, verbal IQ, per-
formance IQ, and 
processing speed, 
with an optional 
general language 
composite.
Formal child in-
teraction
Two sub-
sets: ages 
2.5 years 
-4 years 
and ages 
4 to 7 
years
Trained profes-
sional
Takes 30 to 90 
minutes to com-
plete, depending 
on the age of 
the child
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Instrument
(Reference)
Description Method of 
Administration
Age 
Range 
Administered 
by
Administration 
Time
Adaptive functioning
Adaptive 
Behavior 
Assessment 
System-
Second 
Edition
(Harrison & 
Oakland, 
2003)
Measures 
adaptive behavior 
skills in three 
broad domains: 
conceptual, social 
and practical. 
Behavior 
rating format 
completed 
by parents, 
teachers, or 
other caregivers
Birth to 
adult
Psychologists, 
social workers, 
neurologists 
and others
Takes 15 to 
20 minutes to 
administer
Scales of 
Independent 
Behavior-
Revised
(Bruininks, 
Woodcock, 
Weatherman, 
& Hill, 1996)
Measures 14 
areas of adaptive 
behavior and 8 
areas of problem 
behavior. Four 
domains include: 
motor skills, social 
interaction and 
communication 
skills, personal 
living skills, and 
community living 
skills. 
Paper and 
pencil reported 
by caregiver/
parent
Birth to 
adult
Trained person Depending on 
which scale is 
used 15-20 or 
45-60 minutes
Vineland 
Adaptive 
Behavior 
Scales, 
Second 
Edition
(Sparrow, 
Cicchetti, & 
Balla, 2005)
Measures personal 
and social skills 
for individuals. 
Includes measures 
across the 
following domains: 
communication, 
daily living skills, 
socialization, 
motor skills, and 
maladaptive 
behavior index 
(optional). Versions 
available to 
be completed 
by parents or 
teachers.
Paper and 
pencil reported 
by caregiver/
parent
Birth 
through 
21 years
Interviewers 
should have 
graduate-level 
education in 
psychology 
or social work 
as well as in 
individual 
assessment 
and test 
interpretation
20 to 60 
minutes 
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Instrument
(Reference)
Description Method of 
Administration
Age 
Range 
Administered 
by
Administration 
Time
Clinical 
Evaluation 
of Language 
Fundamentals 
– Preschool, 
Second Edi-
tion
(Wiig, Sec-
ord, & Semel, 
2004)
Measures expres-
sive and receptive 
language, lan-
guage content and 
structure. 
Formal child 
interaction and 
observation
Three to 
six years
Trained person 30 to 60  
minutes
Communi-
cation and 
Symbolic Be-
havior Scales 
Developmental 
Profile
(Wetherby, & 
Prizant, 2002)
A screening and 
evaluation tool that 
helps determine 
the communicative 
competence (use of 
eye gaze, gestures, 
sounds, words, un-
derstanding, and 
play).
Paper and pen-
cil parent form 
and behavioral 
observation
Function-
al com-
munica-
tion age 
6 to 24 
months 
(chrono-
logical 
age 6 
months to 
6 years)
Certified SLP, 
early inter-
ventionist, 
psychologist, 
pediatrician, 
or other profes-
sional trained 
to assess de-
velopmentally 
young children
5 to 10  
minutes
Comprehen-
sive Assess-
ment of Spo-
ken Language 
(CASL)
(Carrow-Wool-
folk, 1999) 
Measures oral skills 
and the literal, 
figurative, and 
social aspects of 
language. Consists 
of 15 individu-
ally administered 
tests with multiple 
choice responses. 
Test books are 
self-standing 
with images 
shown to the 
child to  
respond to
Ages 3 to 
21 years
A professional 
in psychology, 
education, 
occupational 
therapy, SLP, or 
social work
30-35  
minutes 
MacArthur-
Bates Com-
municative 
Development 
Inventories, 
Third Edition
(Fenson, 
Marchman, 
Thal, Dale, 
Reznick, & 
Bates, 2007)
Measures a child’s 
understanding of 
words, gestures, 
sentences. 
Parent report 
forms
Eight 
to 37 
months
Clerical  
program staff 
20 to 40  
minutes
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Instrument
(Reference)
Description Method of 
Administration
Age 
Range 
Administered 
by
Administration 
Time
New Reynell 
Developmental 
Language 
Scales (RDLS), 
4th Edition (Ed-
wards, Letts, & 
Sinka, 2011)
Measures a child’s 
understanding of 
selected vocabulary 
items and gram-
matical features a 
child’s production of 
the same features of 
language.
Picture books 
and stimulus ma-
terials for child to 
respond to
3 years to 
7 years 6 
months
Therapists, clini-
cians, educators
Varies based on 
the individual 
child
Peabody Pic-
ture Vocabulary 
Test-Fourth Edi-
tion (Dunn & 
Dunn, 2007)
Assessment of one 
word receptive vo-
cabulary for  
children.
Paper and pencil 30 
months  
to adult
Trained person 
with a bache-
lor’s degree with 
coursework in 
measurement
10 to 15  
minutes
Preschool Lan-
guage Scale, 
Fifth Edition 
(Zimmerman, 
Steiner, & 
Pond, 2011)
Measures total 
language, auditory 
comprehension and 
expressive communi-
cation for children. 
Child interaction 
and parent/
caregiver ques-
tionnaire
Birth 
through 
7.11 
years
Consultant or 
expert with  
clinical training
Paraprofes-
sional staff with 
training
45 to 60  
minutes
Test of Lan-
guage Com-
petence (TLC) 
(Wiig & Sec-
ord, 1989)
Measures the ability 
to perceive, inter-
pret, and respond to 
the contextual and 
situational demands 
of conversation as 
well as semantic 
and syntactic abili-
ties. 
Paper and pencil Level 1 
ages 5-9 
Level 2 
ages  
10-18
A trained profes-
sional
Takes less than 
60 minutes to  
administer
Test of Pragmat-
ic Language, 
Second Edition 
(TOPL-2)
(Phelps-Terasaki 
& Phelps-Gunn, 
2007)
Measures the ef-
fectiveness and 
appropriateness of 
seven core subcom-
ponents: physical 
context, audience, 
topic, purpose, 
visual-gestural cues, 
abstractions; and 
pragmatic evalua-
tion. 
Formal child  
interaction
Six to 18 
year olds
Speech- 
language  
pathologists
45-60  
minutes
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Instrument
(Reference)
Description Method of 
Administration
Age 
Range 
Administered 
by
Administration 
Time
Test of Problem 
Solving (TOPS) 
(Bowers, Huis-
ingh & LoGu-
idice, 2005) 
Measures language-
based thinking abili-
ties and strategies 
using logic experi-
ence. 
The Picture 
Stimuli Book 
presents situa-
tions in full-color 
photographs.  
The student refers 
to these photo-
graphs when 
answering the 
examiner’s  
questions
Available 
in two ver-
sions:
-TOPS 2: 
Adoles-
cent ages 
12-17
-TOPS 3: 
Elemen-
tary ages 
6-12
Trained profes-
sional familiar 
with language 
disorders  
(e.g., speech-
language  
pathologist,  
psychologists)
35-40  
minutes
Social interaction
Social Skills 
improvement 
System (SSiS) 
(Greshman & 
Elliott, 2008)
Assesses social 
skills (e.g., commu-
nication, engage-
ment), behaviors 
(e.g., bullying, 
autism spectrum), 
and academic 
competence (e.g., 
math, reading). Re-
places the Social 
Skills Rating Scales 
(Gresham & Elliott, 
1990).
Paper and  
pencil rating
3 to 18 
years
Teacher, parent 
and student 
forms
10 to 25  
minutes
Behavior assessment
Aberrant Be-
havior Check-
list, Commu-
nity Version
(Aman & 
Singh, 1986)
A behavior rating 
scale that includes 
58 items across 
5 domains of 
behavior: irrita-
bility/agitation/
crying; lethargy/
social withdrawal; 
stereotypic behav-
ior; hyperactivity/
noncompliance; 
and inappropriate 
speech.
Paper and  
pencil rating 
6 to 51+ 
years
Parent, teacher, 
caretaker
5 minutes
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Instrument
(Reference)
Description Method of 
Administration
Age 
Range 
Administered 
by
Administration 
Time
Behavior 
Assessment 
System for Chil-
dren, Second 
Edition (BASC-
2)
(Reynolds & 
Kamphaus, 
2004)
Measures anxiety, 
aggression, at-
tention, atypical 
behaviors, social 
skills, and adaptive 
behaviors. 
Paper and pen-
cil rating forms 
completed and 
observation form
2 to 21 
years 
and 11 
months
A clinician  
administers  
the Student 
Observation 
System; teacher 
and parent  
administer other 
modules
10 to 20  
minutes
Child Behavior 
Checklist
CBCL for 
preschoolers: 
(Achenbach 
& Rescorla, 
2000)
CBCL for 
school aged 
children: 
(Achenbach, 
2001)
The preschool ver-
sion includes 99 
items concerning 
behavioral, emo-
tional, and social 
problems.  The 
school aged version 
includes 113  
behavioral problems 
the parent rates in 
addition to several 
questions about  
he child’s social  
and academic  
development. 
Paper and pencil 
or on line report 
Preschool 
version:
18 
months to 
5 years
School 
aged ver-
sion: 6 to 
18 year 
olds
Parent 20 minutes 
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Signs and Symptoms of Possible Autism in Secondary School Children 
(older than 11 years or equivalent “mental” age)
Social interaction and reciprocal communication behaviours
Spoken language
· Spoken language may be unusual in several ways:
o very limited use
o monotonous tone
o repetitive speech, frequent use of stereotyped (learnt) phrases, content 
dominated by excessive information on topics of own interest
o talking “at” others rather than sharing a two-way conversation
o responses to others can seem rude or inappropriate
Interacting with others
• Reduced or absent awareness of personal space, or unusually intolerant of people 
entering their personal space
• Long-standing difficulties in reciprocal social communication and interaction: few 
close friends or reciprocal relationships
• Reduced or absent understanding of friendship; often an unsuccessful desire to 
have friends (although may find it easier with adults or younger children)
• Social isolation and apparent preference for aloneness
• Reduced or absent greeting and farewell behaviors
• Lack of awareness and understanding of socially expected behavior
• Problems losing at games, turn-taking and understanding „changing the rules‟
• May appear unaware or uninterested in what other young people his or her age are 
interested in
• Unable to adapt style of communication to social situations, for example may be 
overly formal or inappropriately familiar
• Subtle difficulties in understanding other’s intentions; may take things literally 
and misunderstand sarcasm or metaphor
• Makes comments without awareness of social niceties or hierarchies
Appendix E
Connecticut Guidelines for a Clinical Diagnosis of Autism Spectrum Disorder — 87 — 
• Unusually negative response to the requests of others (demand avoidant behavior)
Eye contact, pointing and other gestures
• Poorly integrated gestures, facial expressions, body orientation, eye contact 
(looking at people’s eyes when speaking) assuming adequate vision, and spoken 
language used in social communication
Ideas and imagination
• History of a lack of flexible social imaginative play and creativity, although 
scenes seen on visual media (for example, television) may be re-enacted
Unusual or restricted interests and/or rigid and repetitive behaviors
• Repetitive “stereotypical” movements such as hand flapping, body rocking 
while standing, spinning, finger flicking
• Preference for highly specific interests or hobbies
• A strong adherence to rules or fairness that leads to argument
• Highly repetitive behaviors or rituals that negatively affect the young person’s 
daily activities
• Excessive emotional distress at what seems trivial to others, for example 
change in routine
• Dislike of change, which often leads to anxiety or other forms of distress 
including aggression
• Over or under reaction to sensory stimuli, for example textures, sounds, smells
• Excessive reaction to taste, smell, texture or appearance of food and/or 
extreme food fads
Other factors that may support a concern about autism
• Unusual profile of skills and deficits (for example, social or motor coordination skills 
poorly developed, while particular areas of knowledge, reading or vocabulary skills are 
advanced for chronological or mental age)
• Social and emotional development more immature than other areas of development, 
excessive trusting (naivety), lack of common sense, less independent than peers
Reproduced from: NICE. Autism: Recognition, referral and diagnosis of children and young people on the 
autism spectrum. NICE Clinical Guideline 128, September 2011, with the permission of the Royal College of the 
Obstetricians and Gynaecologists on behalf of the National Collaborating Centre for Women’s and Children’s 
Health.
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Who is eligible?
Children & youth age 0 to 21 who have, or are at increased risk for, a chronic physical, developmental, 
behavioral or emotional condition and who also require health and related services of a type or amount beyond 
that required by children generally.
Services available?
All families of eligible children and youth with special health care needs (CYSHCN), regardless of income, will 
receive a respectful working partnership with you and your child’s medical home; care coordination services 
and family support referrals.
Uninsured or underinsured families, who fall within income guidelines, can also benefit from payment for 
limited services (i.e. durable medical equipment, prescriptions, and special nutritional formulas).  
Contact the Connecticut Medical Home Initiative at FAVOR, Inc. at 1-855-436-6544 (toll free).
United Way of Connecticut’s Child Development Infoline
The central access point for Connecticut’s Medical Home Initiative for CYSHCN.
Provides information about medical, educational and recreational resources
1-800-505-7000
Connecticut Family Support Network
Contact for family support, information and advocacy at 1-877- FSN-2DAY
SOUTHWEST SOUTH CENTRAL EASTERN NORTH CENTRAL NORTHWEST
Stamford  
Hospital
Stamford
1-866-239-3907
(toll free)
Family-centered  
Services of CT, Inc.  
New Haven
1-877-624-2601
(toll free)
United Community and 
Family Services, Inc.
Norwich
1-866-923-8237
(toll free)
Connecticut Children’s 
Medical Center
Hartford
1-877-835-5768
(toll free)
St. Mary’s  
Hospital
Waterbury
1-866-517-4388
(toll free)
Connecticut Medical Home Initiative (CMHI) for  
Children & Youth with Special Health Care Needs
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SOUTHWEST 
REGION
SOUTH CENTRAL 
REGION
EASTERN 
REGION
NORTH CENTRAL 
REGION
NORTHWEST 
REGION
Stamford Health  
Systems
Stamford
Toll Free 866-239-3907
Family-centered  
Services of CT
New Haven
Toll Free 877-624-2601
United Community and 
Family Services
Norwich
Toll Free 866-923-8237
Connecticut Children’s  
Medical Center
Hartford
Toll Free 877-835-5768
St. Mary’s  
Hospital
Waterbury
Toll Free 866-517-4388
BRIDGEPORT ANSONIA ASHFORD ANDOVER BARKHAMSTED
DARIEN BETHANY BOZRAH AVON BEACON FALLS
EASTON BRANFORD BROOKLYN BERLIN BETHEL
FAIRFIELD CHESTER CANTERBURY BLOOMFIELD BETHLEHEM
GREENWICH CLINTON CHAPLIN BOLTON BRIDGEWATER
MONROE CROMWELL COLCHESTER BRISTOL BROOKFIELD
NEW CANAAN DEEP RIVER COLUMBIA BURLINGTON CANAAN
NORWALK DERBY COVENTRY CANTON CHESHIRE
STAMFORD DURHAM DANIELSON EAST GRANBY COLEBROOK
STRATFORD EAST HADDAM EAST LYME EAST HARTFORD CORNWALL
TRUMBULL EAST HAMPTON EASTFORD EAST WINDSOR DANBURY
WESTON EAST HAVEN FRANKLIN ELLINGTON GOSHEN
WESTPORT ESSEX GRISWOLD ENFIELD HARTLAND
WILTON GUILFORD GROTON FARMINGTON HARWINTON
  HADDAM HAMPTON GEORGETOWN KENT
  HAMDEN KILLINGLY GLASTONBURY LITCHFIELD
  KILLINGWORTH LEBANON GRANBY MIDDLEBURY
  LYME LEDYARD HARTFORD MORRIS
  MADISON LISBON HEBRON NAUGATUCK
  MERIDEN MANSFIELD MANCHESTER NEW FAIRFIELD
  MIDDLEFIELD MONTVILLE MARLBOROUGH NEW HARTFORD
  MIDDLETOWN MOOSUP NEW BRITAIN NEW MILFORD
  MILFORD NEW LONDON NEWINGTON NEWTOWN
  NEW HAVEN NIANTIC PLAINVILLE NORFOLK
  NORTH BRANFORD NORTH STONINGTON PLYMOUTH NORTH CANAAN
  NORTH HAVEN NORWICH ROCKY HILL OXFORD
  OLD LYME PLAINFIELD SIMSBURY PROSPECT
  OLD SAYBROOK POMFRET SOMERS REDDING
  ORANGE PRESTON SOUTH WINDSOR RIDGEFIELD
  PORTLAND PUTNAM SOUTHINGTON ROXBURY
  SEYMOUR SALEM STAFFORD SALISBURY
  SHELTON SCOTLAND SUFFIELD SHARON
  WALLINGFORD SPRAGUE TOLLAND SHERMAN
  WEST HAVEN STERLING VERNON SOUTHBURY
  WESTBROOK STONINGTON WEST HARTFORD THOMASTON
  WOODBRIDGE THOMPSON WETHERSFIELD TORRINGTON
    UNCASVILLE WINDSOR WARREN
    UNION WINDSOR LOCKS WASHINGTON
    VOLUNTOWN WATERBURY
    WATERFORD WATERTOWN
    WILLINGTON WINCHESTER
  WILLIMANTIC WOLCOTT
  WINDHAM WOODBURY
  WOODSTOCK
CMHI Regional Town Listings
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